Amendment of Drugs and Cosmetics Rule, 1945_Section
Notification - The Drugs and Cosmetics Act, 1940
- Kind: Notification
- Under: The Drugs and Cosmetics Act, 1940
Text of this notification
<frl*^ •#> ^ ° "^P-33004/99 REGD. NO. D. L.-33004/99
9lKcF <H 4k;m$l
(The (Baxette of ^Sudia
EXTRAORDINARY
MFTII—TSPTf 3 —^TT-TSP»¥ (i)
PART II—Section 3-^Sub-section (1)
Ulfa*K it U*l'f$ld
PUBLISHED BY AUTHORITY
H. 424] ~ ^ f ^ f r , ?J3>tm, 3JiHfT 24, 2001 /*TT$ 2, 1923 ~ ~
No. ^24[ NEW DELHI, FRIDAY, AUGUST 24, 2001/BHADRA2,1923 _ _
( miWlf<WI'l)
"^ftwft, 24 3TW, 2001
Wmfa. 604(3?).- 3 f r#I 3#T SWTT T̂TWl" fa^ 1 945 ^T 3#T TM*R *R3" % f̂TTT
^friw Eramfr ^r T ^ ^T?^, sfafa 3fl? TRTT̂ T wnft 37ft£m*r, I 940 (1940 ^T 23)
*Ht TO 12 3#T 33 <$" 3 T ^ | ^ K , iTRcT ̂ R^7 % FTT^T sffr ^qft̂ R ^ ^ F T ^M<4
(T^T^r^TTTT) ^\ 3#R£EHT7t 7Tra.ft. 834 (3T), TTT#3 21- 3T^T, 2000 % 3TCH
qTTcT % IFFT^, STr̂ TT11!, ^FT 2, 7 ^ 3, TFJ^ (i) rTR^ 24 3q^J=R, 2000 <#
3^^PN^^tTTf?Rt^R?TT^'25 3FF^T, 2000 ^ WT^r spTUft *Tt «fc
3#T % ^ k 7T?W 3" "Ĥ rT IJT^T f w f f % M "3 ~^H^ 7 4 1 ^ 3TF^ 3#T TJSTFTt
377T: 3T ,̂ % ^ k TTT̂ TT "3^T 3TMTT£T ^ t TO 12 3#r 33 ST7T Wff viRd^T ^T
wr^tf^m, 1945 ̂ r 3fhrTraitor^T#^f^TT[HHrnfed frw*FM\k 3wf^>
1. (i) FT teqf ^T Tffer T̂FT 3ffafa 3#T TRPR (—cfRT<:71 ^ ^ )
tw r ,2001 t i
(ii) 11 ^Rctf, 2003 ^T jpfrT ?ft7
2649 GI/2001 (1)
2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
2. sf^T 3#? I^CT^ "STTWf £PR, 1945 ( ^ ^ ^ ^ ^ ^ ^ ^ ^ j ^ ^
TFTT) % *mr-4 ^ ? f f e *3nW % WR R̂ ?fofor M37PTRT afc <fiKJcfr<ri[" Vm
3. wr£TOt%twr2l *?-
(i) ^ 0$) *f sFR̂ eft (IT) 3 iR^1)^f^fe?ps& 3T5?RT, ̂ teBf 3qtr 3^f ̂ T
(it) ^ C r ) % w m , UnMk<\ m m-.m^ P+u ^wR srof :̂-
(ST) M ^ i d l ^ ^ 3 r h 1 W ^ PjP^ldl VlMtf t ^ * T R c f $ t a f o # ^ T ^
affafo PM"! ^ r a n t ?t sffr fcR} ̂ ^ ~ ̂ yr r̂ 3̂ rr STftrê r IRT afĵ lfcd
dM4)j|%1^P4Pi^idiSHTP^ftd 3T)T$^% fair 3 ^ NH MII^^K! SKI "SR̂ T-
41 ̂ ftocr 27^7% mft VHKI pchiii w U^ITO srfrnfati
4. ^?T ^ m f % fWT 22 3 "3^rf^Fqf ^R OTTSR ̂ ^ ?rf̂ rT 3?R" TT^ %
^TR R̂ "^^fk14l 3TR tf^R^H WTOf ^R OTTSR ̂ ^ t ?Tf̂ T 3fo" ̂ K T*t
5. 3 ^ ft*ref % f w r 23 3 " i M ^ I "T 3TSWrT(i) # P l P f e fo^ft ^T *TT 3RT
6. ^ PlW %1WT 24 %^TPTTR, pHMPtfftsId f^mW^TTTnrr, 3T«rf̂ :-
"24 3MTcT a^f td % fan; -3Tf̂ T 3FT IR^T # ? #T-(1) 3TTCTcT 3Fpf§T % far*
3^'IMH # W ( t ^ 3ff^T, *IT eft <RT faPwidl 5RT ̂ Rl% W ^T f̂ FTt % 3T#T
pt|PwJu| c f , p ^ T T ^ p ^ i j | ^ 3 ^ ^ [ ^ ^ 3 ^ T ^ f ^ ^ % 3 1 # T 3 f M ^ ^ f ^ 3 ^ ^
>MpW»l %fefq t^r M M M gffo a^fcd ^ , SFR^t X qf P^PiR^ affaWt ^ t ^ ^ T
3FT sft^Mt % fcre[ ̂ M 8 -̂ ®m\ spg$\ X [̂ r̂ iPiRtd sWrqf %%TT ^R^T 8-̂ 7
[MPT II—T5P*g3(i)] MTW tpnjam: araranr 3
3jidft«W 4»1-H ^Hl ^lJll # T ?-Ĥ> -Ml̂ ̂ T faPwidl SRr^^T 9 $ faPwId! ^TOTfft 3TtT
^ 3*ft <MI<Ild+dl 5TCT, f ^ f t d 3 l h W % ftp? 3MTTT 3Fpf$f % fatr 3 ^
(2) ^7T f&fa, JPFT S TIT tfFT 8-sp # zwm 3F$$fa % fan; fo^ft 37Ft^T % *T&
^mt ^fav^t Mm tf Am<& forr ̂ nt f^r 27 7̂ % SP#T ^ ^ I - V ^ I IWITO
^ «IKl r*H f̂ RT, %^fa *K«bK % 3^1<H ^ F̂TTcT 3 ^ f a ^TR>^R *r%rrr l"
7. Z33 fom % £ m 24^7 % TFrqKT iHHlHfislfl 1WT 3T?H*nfo7T f^ir ^Tint,
U*PN=I ^ # 3R# % fair 3TT^T, s p p r m TTTteRt ^ ^T eft T$ faPwIdl ^ t % £RT
f̂ R% TO ̂ r fwrt % 3rak 37hM % te^r r̂r tew % f ^ fefaiTPT «TNF ta
3 H ^ T t T̂T *TRcT 3 ^T% f $ w fa f ^ 3 # r r f SUT *TT # f̂ RT% TO faflT sfafa %
^T% ^̂TPeT <wfa<W (3) # f^Hfe: tp^r CT̂IT f^MrTT ^RT T̂ 3 ^ 3TR ^ -H^+d:
e W H H R d ^ ^ H - 1 3TR^T-2 xf r^rnR^ ^H | i i rmT^R^T^FT?F>I
(2) J W t ^H^tcTT 5RT *TRcT # ^T% 3Tfe^t ^ far ^ g i ^ ^TfteRt ^ ^ rfi
4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)1
(3) (i) JR T̂ 40 4 3TT^H % WQ, 'TRcT $ STRlcT ^ ^ WfT 3TR HtRTfr % far*
(ii) T̂TTFT if 3TTW 3̂ T 7 ^ % forr TT^T 3Tfafa % ^pR^l W l % fair y^q-
^R^; 3 # 4pH |̂tM«l *1R^£RT f̂dU=W afafaqf % d ^ c M u i % far{ ftrr T[TT
fokt 4^Wdl 3TT^T % tnx[^ if, S ^ F 3Tfafa % fair ^ T T *PT ̂ 3T?ft ^ k
(4) Ttffcr, % 3W ̂ KT, C M ^ I *TMt ^ t , ^ ^ f t ,1100013?W ^ 3ffa
^fer ^t fokt 3T̂ r srre 3̂ mT sM 3mr %^(k <K<*K SRT ̂ m - w r *R 3#Rjte
fagt 3RT # ^ 4 ÊneTR % ̂ 2W *£ c ÎT ?iH "0210 fafeflT sftT H U ^ I ^ T , 04
<?TN^R«T, 1 0 4 ^ 3 ^ ^ ^ " % 3 T # r ^ ^ r ^ ^ i ^ % i d ^ ^ T i ^ ^ n T T i T t i
f*P 3ffa 3^fcr, *b*<R4l iTNt T̂Pf, ^ t f^rft *PT ^ W % ̂ 7T if fokr # ^ ^ S^lfa-*
^mrn^R tr«iT?it frst-Tjtf.) % iTHnr ̂ ^ T TM 0210 t^terr 3fk HHWI*«T, 04
H H ^ I ^ T , 1 0 4 - ^ 37k ̂ ITNT $ #̂ F ̂ ^ l lH* ^fe ST7T TOT ̂ t ̂ f t 3TR 33cT
sr̂ Rnr ̂ t Tjpr ^rk ̂ #^ ^ H R % ^ r ^ am ^ ^ T SRT ^T ^-^"ten % 3r*frr
(5) 3TT#^ SZFT % faq TO F̂TTT 3T*RM ̂ TT T& ̂ k T̂ WT ^R# % t%TT ̂ ft
#HTI 3H^NHTnft*l()SK!^i^3^^fe£RT^
mfeRt^RT ^r F#m M îRd̂ f ucuwlfari *PT i t t r̂> t d^k IT 3frqfaqf %
tort^W ̂ r ftften1! ̂ ftr ̂ k % fcrq; 3T^RT # 1
(6) srr^rr qRcT if sp^rr fa^r 3 fejkt ^ T ^ H4)'MMI ^r ̂ t# i^ - TT^r ^ k
^r w^r ^R# % t̂ ni ̂ nt ?FTT f̂r 3rNt«r % T ^ T , r̂ra- sftr t^?r^T % forr ̂ ^TrT
(7) 7^ T̂ T yfcT f^^d, ^Fd«w ?t ̂ rrefr t T̂T # ^rat t rr> ^ ^ I w i m»m ^t
t^fl wici %IriH din "tfr 3H^M ^H< ^t^k^T^R^rr^rnTTTi
[MFTII—T3Prg3( i ) ] MTOT ^T TIPPET : ^MINH"! 5
(8) -3̂ " l^mf % aro^r ^ ^ r r̂a?" ̂ -i^Mdi r̂f?rT "ZIT T%?T fedt 3^ftr l^^^l"i % l̂ nr
8. ^?T^mf%1^Fr 25-^7^vJMPi^ ( l ) % ^ ( ^ ) % 1 T ^ ^ ^ ^ T ^ ( i ) % -
WTTTl^#TfecT7T§T^F7TT, 3 T ^ >
"(i) W 3 # £ m ^r ^T $W$ ~Q\ WT^" 3T^T 3to ^:WT3t w t 37WPR, 1985
( 1 9 8 5 ^ 6 1 ) ^ 3 ^ 3 T ^ a R R ^ f r ^ % 3 T # M ^ 1 ^Mf^gri"
9. 3^r ft^rcf % i w r 25-^r % T^rn^ InHi^ry d £ m 3fcr. ^nfocr tor ^n^ir,
"25-^. TrgpH faf-mldl £TCT faftfe 3 l N W % feR *fa*$*<"! IWlum*
(1) 3^ft ^McTT 3RT faftftcf TT^ ^ 3#^T 3ff#pff 3TW 3TN% t̂ ^ t £ f W %
<frK£l«b<ul % W J 3 W ^TT^T f^TT ̂ T ̂ T T sfft WT-41 if TT^T #TC^R*r ^TFT
Tr^:qF 3#r fe"^ f^ f tT^r f̂ f̂mtcTT % w i ^ ^ f t "3T fate 3ft#rcf
fafaftd ^ ^ T 7 ^ 3 T N W % W T 3 3FPT-3WT <F*14<UM"I W ^ ^ 3T^7cT *frT I
10. ^ tT 1wff % £ m 27 % Wmr{ f ^# l fe rT 1WT 3trT:^nf^T f ^ r ^TT^,
3 ^ : -
"27-^r. <ftHJ|<Mm umuma WT3vRT : (1) fcm 24 - ^ TffafccTtf^ aftc
^ T *f <ftH£|<MU| MFTO % frF{ 37T%̂T ^TM ̂ ^T# ̂ TT 3 ^ i m TTrfwft 37W ^
6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(1)1
(2) qfc STJ^fr ^T ^ F P T (1) % *R^7 3 qqifaEfe 3R# % f̂tcR ^*j)*M"l
WWm WZ ̂ ?f FTcTT t, clt 3F ̂ k TR^R ^T 3TCfcr *R T̂%nT 3TlT %=£k ^R^R
w*3 ?£t f$t r̂r*f *R^ % TOT^ ̂ r) w 3jiciw<!t» -m$ ^r% tf«r«r 3 ̂ srr^r vtfvt
11. 3^ftr^%t^2M"3^^ft^^aT^
^ ^ t 3T^T% % t^fir 3Tfw^TM ? T ^ 77# ^TRiT I
12. ^ ? T f^mf % £FTR" 28 % w ^ fanP^d ftm 3r?r:̂ nforT fer ^nf,
"28-^. <fc<jta><U| UMIUIM̂I **>> *IHMfa- ^ R ^ W mm* *R <T̂ fa
^ ?t ^r^r Pwfafl *rr T* ̂ f fa*rr "̂ rmT, T̂R> ?t# *PT rrrfte ^ nk ^ ^ t srgfa %
i^fci(«WM?rTr:-
*ft cT̂ 3TT^T *R 37l^r ̂ TRcT Wf fa^ ̂ |"
13. 33?T totf % ft*PT 29 3 T R 7 ^ % ^TR TC IHHIHHSM iRnJ* 77IT m̂»»TT,
V ^ ^ r tor % 3T#r 3 ^ p m jnferct ^RT T̂TT̂ 3 ^ ̂ c q ^ ^qt%, ^ r ^rr^r
% TTRT ?N" % rfkr farf % *fl?R ̂ Rfrr W R T ̂ t srifcr ^ r ̂ m 3#r %^#r <NW>K,
^ft ^rm ̂ % *rK, ̂ ft ̂ 3TT^^7 ^ r^ , A TTTTT̂ tf ^r^^chdi ^r 37^ toR
[^FTII—-gp^3(i)] HTOT^TTiam : •̂HÎ K"! 7
14. ^?T Ff*rtf % fim 29 % ̂ r̂ mi; W f e 1WT 3??n̂ nft?T f^ir ^K?IT,
MJ-IIUIM̂ eft £FFT ?mt ̂ r W R ^ # 3 STCTETT W F Ht 3 ^ p F R ^ n t e r t ^ ^
^7%^^RWf^r^R^^|tT, 3TT̂ T 5RT ^ ^ l * ^ i ŷ iuiLĵ eft T̂ fr sp#r, M"
*TF 3 ^ 7TT#, % fcfTT tjrrfcT: itf t ^ f t ^ T̂cft ^ft ^T ĉT, f ^ # *TF ^NfacT F^ <Rl^l*RU|
^ W £rar % 3T#T 3 ĵ?rm Hifwrt SRT ^#CT 3TÎ T 3 *#r?r ̂ ff̂ r, an^r ^t
tnf§T % cTFJ fcT % *ffcT? % ^ k TR^R" *ft 3TCk ^T ^ T T sfa % ^ k ^ 7 ^ R ^ T T T T ^
^t T$t ^TR ̂ R % mnid ftrc} *TF <m<*yq<b w$, sffr ^ *n*rft 3 wtfltfwl ^t sntf
ftrarc ^cT wi - ^r sum ^m ^T# % wm^, ^T ^fa 3 ^ srr&r ̂ ̂ 3%*M3F
15. ~5̂ fT TĤ -MI "%f̂ RT 31 %^7H^fHHiHRsldft2FT773T^IlJJll, 3W^-
"31 +fdM^ 3n^^^3fafojft%1?ITT*lM<+>:-
^ftf F>, % TTT̂ F ̂ T ^-flMH T̂FT to" T̂TrTT F afh" W £ m f *f fa%?f T R W T̂F
3 7 ^ 1 ^ ^T^ % f̂TTr ̂ n^ FFff fe ^ t t T^t 3Tr̂ nrT °ft ^ ^ffafa 3^T TTR^ ^T 3^qrirR
R̂cftF'SFT̂ TFh
^RnJ q^RbrHI ^T#T % fan 3^|Rjd 3qh^f, Tffe «WlM # T ^ T T , ^
*ftf F>, % fan -tiRcF ̂ #T f̂t 3FTC£ft r̂ (1) 3 faPfe F * H^ 3FTC}̂ t Tf feT
n ^ T *TF 3T3**TTCcT ^ ^ % fan. ̂ fp£ ̂ frj- f̂ 7 cftf T̂ ft 3TFTTcT ^ t fTf sfafa 33xT ̂ FJ^t
^T^^MHH^RrTttmHFT31R^f I W ^ r ^ r H I 3 ^ 1 % fair SFF r̂ft r̂ (1) 3
^ t W » ? ^ t t ^5f ^ 3 ^ T % for W& ^^t^f^^RWm
MVir^i+oH^d^^^^Tf ej^H -HWul^fclPlR«<d&l
^ F ^ T̂F 3^T f̂ 1 3 ^ i m w t e R l W t ^ft 3Thî T % 37FTTcT ^ 3F̂5TTcT ^ #
^^TT r̂ i-H*h) ^^fvi^Vl^HT^^31^T3TFncT^tdKly 1̂"-Hid yfd l̂d ^"^TFI
8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)1
l^rJIJT^lttsp^Nqift* HIH<rll*f-fl^llHH HlJW'fl i ^ **»Kufi %fo*^Ti<rlRgd
3 ?\m<& fair 1TTJ, m i t t ^T^F 3 ^ cffift, ftp^ afafa 3TTCH IT 1«1 itfacT
<H^M^?rr^^^fo#3fafa%3Wcr^<H-pid *< ^ ' i n w
16. -3 r̂ Hi i f % t i n 33 % ̂ mrr̂ ftprM&rr fan 3fcT:̂ nt% f̂ rx anrnt,
w33-̂ r. <̂4>r<1 3iwdM IT ̂ rpn faterr R̂*TT ircr fttW % ^I^TR % for
a r̂f̂ ff̂ rafrmra":- i22-t#*wNift*jifa«bM) ^it3rtifa^2r)^tiT3T3, ftm*w
3HTcT 3 # m ^ ?TRT 10 % 3T?frT 3RI«TT ufafa.fi I , d.d'k* Mfw l ^ R ^ R ^T^"
-H^I-0 ^WdM IT-WNTI r^li^c^l^n'%r^Rhc^l 3^*1-0 SKI* ^H^cj| f t l f 1T1*ik
TTftcT qft'wratftwiddl f̂URrf *ptf ^ M , 1 T ^ f t l f 3 ^ t T « f t l * p t l t M&m
^ N t ^IW<l*diafft % for faRbrHI ^T 3T̂ TT ̂ f , ltr$?T #FJf % 3*T1R % for
fa-H*l -H<*W-(l̂ -WdH%Fc|fa>c l̂ 3T«TTffR7^T^W-d felRhrMI ̂ fWT%TWHSRT *|W|*
^T^ " IWlftld t^Tr^T^, HHpHftdd ^ % 3 1 « l # T S f f l w t a r *!T -H*Ml, afWT?fJ-
fa) JR*I 11-^3 3R̂ rt% % 3?IH STR ^ artifa i^ ^ ^ 3 fewr % for
3T^iTTr^ t W *n^ i ^ 3T^r^ ̂ ^ ^ T ) ^
^Tqnri
C@r) 3T r̂f$mR>, 3T5?rt% % am^r ^NiPdd <TCT*TT I T 3fatW ^r trati OTHPPT
IT ^ f l F d *f ^ f n R ^ ŝqFT 31W T$ a^T w f f T̂T foi" 3^31 NH Hll̂ l+l-i) URT TTW
W T IT Mli^l^d tor T̂TcTT &, 3FR RjPhrHI 3lt^*lR*iI % l^t^FT % 3TOR «IH^^I
ftif ^'^^'srf^^t^Fft?t:^i*idi T̂RTT IR# ^ Ttif IT ̂ TW ft, ̂ rt ̂ i ift
i t fafocn ^ M T 3m^T^rr3# % for fafarsr *tft 3T%T IR# t, itf^r ^Rd4I %
^TT^ - % aqrpq ̂ ft^R % fo^ I^ITI
( l ) 3T5$rf%^Rt, 3T^TFR JTffawt 3TTT ^T ftfatT tflftTfl tot *ft £ R W ^ t ^
TJ31T %TTPT 3TW3TT %fl1T it^TR"3, 1?f ^ J 3 # "IT 37tlf*T ̂ T ^fSR'l tor 1T1T t">
^ r ^ ^ ^ 3 ^ t | f ^ ^ T O T 3 T r ^ # ^ % ^ R ^
iftftfcrift^M *ti 3k i J ^^ i ^ ^ i ? t c f t ^ r ^ i ^ ^ ^3^q t f fT r ^H^ r f i
fa) 3T^rf^Rl, 37̂ ?rr% % 3TMH aimidd * T̂RT ^ i t wr? IT afaftraf ^t
imr, 3Micr ̂ 5t CTRT̂ t̂ Ritcrr % i n , ^T frit ̂ r i n 3ik icrrt̂ RT%foT3Tr̂ t̂ f?cr
http://ufafa.fi
[MPT II—~qp^3(i)3 *rrar̂ 7T3m: awmnui 9
(s) S^fcWRt T̂ ft 3RT 3T̂ TT3ff ^ , ^ ^ ?t, <tft ̂ ^TTJ, f̂t *H<*K1 3{WdMl
£RT TfM" % Wmt % fc^ ^ t 3lM^Tf % 3TPTT?T % fatj 3TTCTrT SPpf^T % Wsti ^
rn^sfaft t , ^ WT-WT *R srfaftzpr % 3-T̂ M III % 3^fk ^K 3 *HTTT TTJT fetff xf
(*r> STM^I i t e f̂eR r̂ f^riM % srcfr T*3T ^n"ft 3#r fo^ft T^R^KT 4>mllW
3#^TTT^T 3 3TFITcT ̂ R# ^ t ^ t ^ ^ T T |"
17. 3 ^ f t ^ % f d ^ 3 4 ^ ^ r f ^ ( 3 ) % ; n ^ T T C
"(3)TR^T 12 Tf TTĉ T 3TT^T % TTT2T, TT̂ f̂ afNI^ % f^r ^ r̂qrr ^ t 1̂ 7̂ 3̂ T TR^^
(4) xfa s^fcr N̂fl, ch^ojl TTpft T̂FT, qf feft-1 10001 % ?(\ ef$ZJ 4Np" T̂T %#T
^R^R £RT ^TFT^m ^ "̂HT 3#RjfacT fo# 3T̂ r ̂ Nf7 ^ t fa*ft 3RT ̂ n̂ TT T̂ ?IMT3Tt
%^:TR%^MTT^73M^"0210- i i r i chHT^Mf^^ t^ , 04-MRH* f^T, 104-
^ T^ T^T^T" *f ̂ ftrr ̂ % fcn? TOT ̂FT ̂ f r i
18. 33?T 1wff % ftipr 34 % T̂ rTjrT innlnfyd £ m afcn^nfar f^ r T̂TTTTJ,
awfa:-
"34-^. ^R^R> 3J*Mc1M T̂ WRT 'R|R>OHI W-TT IRT ^ t W % ^ T R % fan qf
3TT#pff ^T *fr?t *TM *f 3TTW ̂ R^ eft 3^pf% % %TT 37T d̂": (1) ^IHrhl TFff *TT
^ T ^f% ^ t ^TFft talcfddl T̂RcT ̂ ^ ^ ^ M ^ T T ^ ^ r f f ^ , - j i t ^ T r ^ T T ^
f̂ r*r>HI W t ^|c|^chdl3ff' % frTTT ^ r * ^ l ^ t 3T̂?TT ^ ^ £, ^ ^ T # T # % 3^RR %
2649 CI/2001—2
10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
S*ffrR% fair tor 1 2 2 - ^ ^ ^ N R ^ i r M d ^ 3 f N W ^ e f t ^ i n ^ ^ ^ F m ^ ^ ^ t
3^TRT % f̂TTT 37T^T, foot W+lf l 3RMdM *TT W*TrT l̂ lRhoHl WTR % fo#
(3) S T C ^ 1 2 - ? ^ 3 g c ^ 3 T T ^ % ^ f l ? ^ T ^ ^
(4) tffoA$^ fe 3 ^ ^ T nmt^Ft, q t f^ f t -110001 %ZTT ̂ j #^7TTT %^fk
% ^THR % ̂ mzw ̂ 7§T?TT ?fH" "02 K M i ^ d V$ ̂ f e p tc*T, 0 4 - M ( ^ * f ^ 104-
*ffar TJ5 x̂ T̂ T Jf " W ̂ 7 ^ % far* ^ T T ^ t ̂ H t l"
19. ^?r toff % tor 35 % w^ UnUTm tor 3trr:̂ nfqcr tar ^ i r ,
3 ? ^ : -
^N^chriat %1^TT fal^cw ̂ t 3T r̂r ̂ t , #??T Tfto %^rnir % !Pter ^ tor
122-^ if *mr nPxif^d, ̂ t sfaMF ̂ r sfh^ TTT̂T if srnicr 3s^ ̂ ft arprf^r, srprnR
(2) T ^ ^ a ^ r f ^ p ^ f ^ r ^ t ^ - i ^ f i c l ^ • # ^ t t ' , W^T^^cTRfe^ r f kTTRT
% *ftrT7 %^(fa ^ F K ^ ^flrT ^T ̂ RcTT t 3ffr%^tg ?WRf W^ ^ t ^ f t ̂ TR ?&7$
% W ^ #*ft ^ Wm*6 3TC& 3nH-H*-di 3^ *TWr} 3 37^ feTT SR̂ cT ̂ 3R
20. "W^RPTf^a f ^^ f rgn f : -
[*IFTII—-BP^3(i)] •HTOI'SRT T H J N ^ : ^•HI*JK«I 11
^ tfl $<*»<) % 3TPTRT ̂ t 34-Ĵ fCcl % f̂ TT 3TT5MI
1. ^ q - (î r w , ^rrc, "ter ̂ r r a#r
f^ritT^%'^T) —-
^^f
(1)
(2)
(3)
3. 3/^T ^ % M sfafa 3fa TOP-Ff
•^Rlft £ m , 1945 % £ F R 24 ^RT W 3T^TrT JTĈT 9 3 rTTTtW ^T TT37
^ ^ T , ftrcT ^T faMcTT 3 £̂ TT3TT fair f , ^ F T ^ W T ^ / ^ t l
4*. f̂/giT 33%^FT, '̂ RcT 3 3MTcT *ft
^ ^ T ^ a r N W ^ ^ H ^ R T T ^ ^ ^ ^ u i yq | " IM^ , ^1^7 tFFT^7 r fT^^T^ t , ^ t
%^m-4l % arefk ^^gl^ui mmi WTT mfe
^Rr^tw7FTT ̂ \ aftr CTRW ^ fafw*it i
5*. ^f/pT ^T 37^rfwr 3#T ^?T% 3F#T
12 THE GAZETTE OF INDIA ; EXTRAORDINARY [PART II—SEC. 3(i)l
6. "3rfafa zftx VWH ̂ mrft f^w, 1 lM5-%^fa % wfa #3T ?M 021 o-frjiV-Hi
^ f t r ^H^T^T , 04-^TTOR^T, 104 -^T •3ttT^TT" % 3TSTH WTFT W T —— -
^ j ^ ( ^ -gfFT TFFT) SRT *RcR7 % ^irq
^fT{ ^ ^ k " ^TT 3R ^t *Tf 11
?rsJTrf?R
v ^
tT^TR
M^qfrTT % 3 # f ^ # ^ T / % T -—
WT:
cTRte:
(m)' V[W\ 8-z$% ^TR <R HHfn fed TR T̂ #R*ITfocT f^TT T̂TTRn", 3 T ^ : -
TR^T8-C£
(£m24^f)
3Tfafa 3#T !RT^R WTTft j ^ T , 1945 % 3T#T S^J r f t i f fal-fc ^ M
3rM^rarf 3TRTTCT ^ R # ^t 3T^rf% % farr sn#vT i
*%TT • (TTJT̂ TrTT, ^TOFT, ^RT 3l t?t ^ ^
% WT ) ^ R f (̂ RT W , ^ W T , ^RT 3fR ^ - ^T ^ %
WT) 5RT faPHffld ̂ ft# fafafifad 3T>#Rt ^T 3tfm ^FR ^ t 3 ^ f c l % fcpT 3?T^T R̂cTT
f/^R#fl
(1)
(2)
(3)
S . T^TT ^T% ^ T 3ffafa 3#T 1RTFH WR#
H*W, 1945 % £ m 24 £RT ^TT 3T#RT JR^T 9 3 cTRfe 3JT ^
^ R ^ T te ^R faMcTT 3" ̂ TTW fo*T f, 7FR^^RrT[|;^R#tl
[MPT II—"*yg\3(i)] MTOfETTflm : T̂OWRW 13
4*. 3 / ^ - ^ T % *n% *rrccr t STTCTTT ^ t ^n# w f t
(qpq- 3#r <RT w ) % TTT̂nr ̂ £mf % TT^T-41 %
smk 7frR#fR°r MMIUN̂ W I T -- - rrnfo SRT T̂R>
tor W «TT 3ftT cTR^S cT^- foftwM fc I
5*. 4/pr — ^T 37$rfWT #T 3^1% 3T#T ^HF* TTTI
^wff % 3p#r, sifaM % ter m facuui % far* RI$WM *fa sppfa *TT s faM
% faPwH zft 4\-$\\k\ %«TREp$% I 33rT ^ - ^ f a l ^ 4 * Mid -HHH 11
6. 3|fafa SiRJRWTWnftfWT, 1945-%^k%3T#T^3T?tM0210-rx|RhoMI
sfâ TTORSZT, 04-*HWU»r, 104--qfa 3TR *pfar% 3T*frr̂ ETR T̂RtfW —
cTRW -~(T$ft tffo ^ F T ) £RT W*bk % ^
^TT^R
^
T^TTJT
^TFT:
c T R ^ :
(n) JR*T 9 % m $ faPwIdi SRT ̂ r ̂ rcraft 3TR ̂ ^TTCR w f % ̂ TH ^R RIIH-HICII
fa) TR̂T 10%^TPT^RrHHrHRsld^FTT<yi -HH'II, 3Terf̂
TR^TlO
( 1 ^ 2 3 3fa faro 27 M)
3Tt̂ r̂ fRTRn^Frf̂ m', 1945 % 3pfrr 3J)iW (^-i^il 3 fainfe ^ ^1^*0 %
3MRT % fcTC? 3PJ#«T I
14 THE GAZETTE OF INDIA . EXTRAORDINARY [PART II—SEC. 3(i)l
S H ^ T wrr CTRW
(^UMcbxIJ ^T ^RT ^ R̂T W ) ^
-fa$ ( ^ sfa Tp- w ) ^ fafaffo 3Thf̂ pff ^ afffa"
^T S ^ f t d # ^TFJ-WI *R ^Wlfthd 33?T faPwIdl £RT Rlfaftd ^ t f 3R*T sfafa T̂RcT
^ 1 ^ :
cTT^k:
4. spjsrf̂ rarft, 3̂ rf% % smk mz ^ # ^ % ^ T R 3 fa*ft MR^W ^t
[ *tm II—WQS 3(i)l *iror *PT TFSPTT : <M4IIMKUI 15
3T=J5Tt% W3X cTRfe"
( ^ M l d ^ d l ^T T̂TR" ^ ĴJT "qrU)
^t %tf ( ^m 3TTT xjjr w ) % SKT fanftd
3T f̂Tt% ^ ^iTchd ^ t ^TFt, 3 ^ 3p#T % # F T f̂ RT% fc^ z^ 3 ^ f a fl^T t , *rRW3
37FTTcT ^ R % f̂TTT 3RJ?rf$T ̂ t T̂Tcft 11
3. 37Fn?T^t^R^Mt3Tt^Tf%dTtT:
^ p r :
cTRfe: ^
16 THE GAZETTE OF INDIA ; EXTRAORDINARY [PART II—SEC. 3(i)l
3TfcT *FR ^ t cTHte % WT f̂ PiJ-llrll 5RT ̂ ^ ^ T ^ ?MSR f^x ^TTT^ sftX ^
^ R ^ ^ ^ ^ ^ ^ r T R ^ M ^ ^ N H y i ^ ^ l ^ ^ r f ^ r q ^ l
3. 3T̂ ?rf%*TRt, «7Rrf ^ F^Mdf ^ t 3TR" *n*T FT /P»t*£k>-(»l ?TR37 ctft 3|t? 3̂ T#T
4. sppf̂ mRt, 3T r̂f̂ r % 3i#r ?m ^R T$ vtf % ^ f^R 3 IWt MR^^H ̂ t
(^) TR T̂ 11 % ^ K HHfHRsId TR T̂ 3T?T:̂ TTfqrTf̂ TT ̂ TTTTTTT, 3 7 ^ : -
IR^T 11 -«F
( f W T 3 3 - ^ ^ f )
3RJ?Tt% WTT cTRte
( • ^ T ^ / ^ W d H / ^ M T l 7RSTT ^T T̂FT)
%3T- TOW- - ^ t -
3 SpqcTT ̂ f ^ T ?RT ̂ TR f̂ t^RT%t^
3 T ^ r R ^ ^ R ^ 7 P R - ^ ^ ^ ^ f f K T ^ , (TRT^T^R)
[^TII—TgTg3(i)] ^nw^TTra^ : arorarrf 17
7hT%7tfipff %3̂ TT%TpfNR%Î HJ Hi*) M^foi ffffafM^#^f
Wfifaz ^ t W$ ^ t cTRT̂ $ ^ ^ tft 3rfr % fcTT{ SfcT # f t I
3. 3 T m m ^ t ^ ^ t 3 q h W % ^ m : -
a i l ^ * l HIM MMI ^ ^ N l d ^ ^ - H ^ l l
C T R W :
34$! im s fw#
i. ^ a ^ f a W*K1 3<^dH%r^r+oni a^«ita5i^ratrr^r+rHiWTT%^TR%
«H*rtH*l # W#lrl ^t «H^n I
R^Rl4) 3 *telRd ^ T T I
T̂ETTT%r̂ U JVll ^ W s f a ^ W T ^ i**il ^ ^ d M^wlftlW SKI T M %
^ F̂T # ? W (tf^), TK ^ H , WftcT 7f*T^ STPTRT ^ ^ 3Jk ̂ t ^ 1$
(w) ^ T i2#^^^%^rFTtrrftHfrHr^d^r7W^rnFTr, awfĉ :-
" w^ ^t ^ -CIMH wrr
CTRW % 5RT 3rht^ 3ftr Tram w*rot iwr, 1945 - ̂ # T % smk
2649 GI/2001-^
18 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SBC. 3(i)l
^ # ^ 0 2 1 0 - f ^ ^ 3 ^ e f e 3 ^ 104-T?for3fo^qfaT%
5̂ q" 12 - ^ p
a f a l N f ^T«rt#TrraT# 37TORT^^ t 3 F p t % % f a t r 3 T T ^ I
^ (qpr ^ TOUT) ^ —
(3KMrtM/MiqTl r^f*rHI TOT ^ T̂PT) 3 -
I ^FT^T 7PT (*PT 3T =TPT) ^ tffî T #TCf %
gq̂ TTT % y<jf*H % t>TTT
(3MmcT ^T T̂PT 3" VCR) TT ̂ t ^ l f e ^ 3 * t # ^ ^ ^ ^ ^ 3 3 f l ^ ^ *tft
3f$lf§T % t>TTT 3 # 3 ^ T̂cTT \ cWT 3 3^TT% ^T r ^ ?TcTT sftT sffafa A TRTT l̂
], ^q^ ^t ^ WTFT t m
. frffe „ (ij^f ^q- f ^TrT^T) % OT sfHfa aft* Tfal*R ^Unfr £ m ,
194.5 - ^ # T % OT TM 0210- M^TT sfa tffaiWIW, 04- W^cHl aft?
i?Tt^^T^T, 104- qfor 3#r ^qfat % 3T#T ̂ ^ ^ % ^ T t ^ W ^ t ^ t i
[Hm II—T5PT3(i)] MRff ^ITHNT : JWICIRui 19
3n^^^dMlH<fl3fafa^^W
W^tf?T^rHTTT ^nT^^RTcT^t^TT^ f l 7
^R: -—
UHIUITT3
^ T q r t e f W ^ T c T T t % 3 ^ M % f ^ ^ K ^ [ ^ ^
(̂ T) T^^39%-^[HHFdf^dlT?^3trT:i?nfTO^"^mt^+ 3 T ^ :
S^r40
Cnm 24-^ M)
?il# 3#r TTHT̂FT wrrft £m, 1945 % 3^k ̂ wr 3 srfaft̂ f ^frw. ̂ %
20 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
3/̂ TT
^ 3 ^ . ^ ^ faPwidl, ^ R f
(M^=T $?RT rW $-ifa r& % WT
Wrft ftMdl m TO W ) ^ 3*T% tf^Rf ?mT *TRcT 3 37FITcT ̂ # % VWfcR ^
0)
(2)
(3)
tf/^ ^ $̂TcT qforcf % fair ^ ^ 1 ^ u | y^|U|i|^ ^ 7 ^ ̂ r # % fori fafaqfcTT
srcr TOTTO ewwlw sr^f t r̂ (1) ?T2TT ar^f t *r (rr) faftfe ^Rnt afc
w m ^T% wr ^ F T ̂ rfT | / ^ f 1
"srtafa #7 TOT<R wnft tor, 1945 - %^fa % 3 ^ ^ T^TTO %, fe^t
forf̂ ifert nt# ̂ t ̂ t, ^fdWui % far?
—- (TĴ T ^ r ^ w^r) IHT "c^r ?M 0210 - far^oHi cmr HHWI^ST, 04 -
tfl+WW, 104 -^3 f tT^RR%3q#T^R^R '%^T^nTr^T^7T f t r
^TT 9FT ^gTT 2 TTT zrgTT W-ifoi 3?FTTrf ̂ ^ ^ \ a f a M f % {frl*j)W"l %
f^pr ^ ^ T ^ ^ T ^ T H W f T C[RW
- OF* ^ ^ w ^ ) "̂ rfafa afrc wm" vm\ fwr, 1945 - %^fa % mfo
r̂ w ?M 0210 - frjf̂ oHi cmr HHWI -^ , 04 - MH-wn«r, 104 - vtfm ww
[MFTII—^F¥3(i)] MlWFTTHTre : ^TRraRT 21
cTRhsr
f^dl WWI ̂ F T f̂ TT ̂ TFTT t )
irm41
(Pm27^i )
l. T^R^N^T W T ^ wrr mfm
%tf (<r*u$$d ^F#PT ^r R̂FT 3frtr
^ w )
^ f ^ ^
(*maw)
(rgj tfcTT) Trf̂ TT *R $, ftw 27-^7 % 3$fa faMcTT % ̂ T ^ <tfa<W<
22 THE GAZETTE OF 1NPU . EXTRAORDINARY .. . _ , [ftta II-^SBCI3(1)1
^T 3fltfW? *fc *Tf*T W W W wm<W ^ 3T£fH 3WwWT^IT <wli I
(1)
(2)
(3)
"# TT^fej^l'HMTtTT^'
(^q-
3 ^ T$1 W ) % TOT ^ ^ fe*TT T̂cTT & ^ t f^mfcTT % STTCrT 3 +IWK %
5. W ^ n t T F T - ^ ^ * f ^ d ^ cT^ ̂ •SRT ̂ Tclf %. '^7W!T-7rcpr^T^T37ftjlH<JU
Wfa^4 ^ W i f e ^ W ^ ^ i ) , f̂KET̂ f̂ T̂ l
^ U P T :
cTTffer:
*$|AWÎ
-''-' T̂$*tt*JMWW ̂ 1<rf4f» <W^l^d Ww^lKt'll M d*%1 '^^ w f f W ^ t S
3. faPmltti *rr ̂ m srfafKT a#R*it arkfo aftr i rom OTH £ m 1945 %
H$wfl ^ f ^ r afafo ^r f ^ rmfe i t *rr fe*T srcTT t, SRT stffacr t^ftwfd$tf
yfdfVii a i ^ ^MT ^ fsprr ^THT, faforTw frfe *rr jnfroft % W W ' #r/^rr
3rti r̂̂ r1c<M«H TWT <JM̂ VI dc*i<H Thsl̂ rrr w^'in 3##r^i^;f^M«iH ^ t " ^ ^ n ^ -
[HFTII^-qp*E3(i)3 MTO W W T O : gJParaTCT 23
Tm Tntertt % mm\ it *TRCT *f Tt$\mlmi ^ ^ipft, ̂ $Mk %>^ fanR ftwuM
% ^ ^ ^ f ^ T 3 ^ T % w f ^ ^ t ^ t l craTfc, gppT^T3TT^nft, frills) % 3 T ^ T
# $ # 3 # T « d > l ^ % ft^T ^ 74%TT, tot '^Rt^T ^ f fT - ^ 4 8 ^ c f ^ ^ H H H i ^ *f
3fH^T^?3Rn'^TFTT^^f^Midd#rTTI
^ W^ t ^3T 3T^FR TjrfWTT % fa^lfacfrK 4 ^T fMT , PqpH »̂l ^l
M ^ M m ̂ rftê T̂ r y^-4 ^f.^ i^f^R^n/^id^i fa^rr .^rr t, ̂ ?t RPwidi ^
*TRcT 3 37T^ 3 T f o ^ fwT 24 cf7 % <ii|pH^ (3) % T&5 (ii) # ^ T feftfe
^ ^ W » J | T ^ T %7TFT TT«^^T^ 3JT<̂ T TT̂ cT ^7% T$ M R ^ H % t>HT 3^pFR
Tni^^^30f^%^^i^^d"^t3^^3#rmT?r^iTi
wfti«j>d ^r te^ 3^PNH MÎ I<+)K°I ̂ d^n Mart wr # "?jto ^nr t ̂ ?f ^ %
T̂W cT̂7 f% ^ ^ qRcrfdd Ttf^TH ?mT/̂ T ̂ 7#?T ^ % ̂ TR "^ TT̂7 W # T ^ O T
21. H^T^Fmf^ t3T^ f t V ^SE*T W T 4 3#T 37T7J 7ft#RT Hpclfe4I ̂ T rfhr f W
22. H^T^Ti f f^37^J^t V % r̂7*TTcTpHHp'lP d̂ 3TcT:̂2TTf*TrT f̂ T̂T ̂ TTTtTTT, ^T r̂fc :̂-
(£m2i (̂ r) 3firmtT24-*FW
24 THE GAZETTE OF INDIA : EXTRAORDINARY P>ART H—SBC. 3(i)l
l . faPwldi aftrfoPwH MUW!I «PT foRfiRJwi i
1.1 *P»1W{ fa^ ^ ^ faPwJ"| qT̂ uT ̂ T ̂ T 3Ttr "qrTT (<MH1<* ̂ , % R̂" WTT,
t-^H Mdl) I
1.2 44tfm4V*llJlkNWl3wt>l ^ ^ ^ ^ I
1.5 Mid 1̂ Hi T*W ^ t H*h yfd (-H^Wd: $m W*#ld) I
^^EI+^l/^-i^l^H TOFT^ ^T^TrfrT (-H^+d: #£T Wilfrid) I
1.7 I^Mdl^t^ ' i^ 'MH fl^MPdfafa^T^tf&TCT'^^aTI
KiRfifeqi:-
2.1 *TRCT 3 afTFmr art? ̂ k % fax* <Pi«ku ^t^n# qi^ft s f a M (niVfafaftftwi/
2.2 ^ T for ^ faJHMl"I^M"H % far* ar̂ TTcT ^TT 2.1 ^ dfortfel'ct W$[ 3ThW/
Wfilcl4i/fti¥lq Hc^Kt^ <VlPc|Hl 3H+flfcd ^Jt^tT^F^cT (4<m^: <%ST
2.3 *TRcT 3 3TmTcT *R# % fair ^ 3Th^ t m fa Pi Pi Icftf *TT M 1 * 3c^f % W
2.4 T ^ ^ ^ ^ # , ^ R ^ # ^ w ^ ^ ^ T ^ W I ^ 4 l ^ ^ n ^ r f l
[MPT II—~qr*g 3(i)] i ror ^ I TFTT3 : aroTOTCW 25
2.5 3^T (cR) 3Ttafa (a^faM) ^r (%) ^m ^t faPwidi % ^lid^ sppnH -^m f:
3.1 £TT sffafa 3ftT R̂TT̂R W^t TWT, 1945 % £ m 74 3#r 78 % T̂«T ^ f e
3.2 ^ T ^ t W ^ t f o F ^ ^ ^ M ^ T f e T T f ^ ^
xf t%TT TTTT M t MRcl̂ H 3TTT ^T ^Tm# ^ ^ t faMu| T ^ ^ 3TT^ «*>KynT 3
tar r̂mr t; *K<£inT % ̂ r ^ r % f^ft' % ftcTFr 3 feu iju fo*ft MRCÎ H %
3.3 PT srfafa 37TT TOm UWl\ fa*W, 1945 % *TFT TX % 3Wff ^T 3^HHH ^ t
3.4 ^ 5KT T̂TTcT 4 ^ ^ l ^ " l WHIW % 3f#T 3TnTcT % t>TF WHm TTc^
sffafa, ^ t rW 3 ^ t R̂cTT, '],"MT1I 3TTT ?J£?Tr ^T # 1 1 , STfafa 3TTT TRTT̂T
TOrft$lfaftra*T, 1940 % 3?«zrpT HI 3ftT3TT^3#rgW^WTTfttWT, 1945
% *TFT IV % 3WTf sfrr -g^f r̂rrq'-̂ PT^ tpC t ^ r T|TT 7t#^Rf%3'FJ^T#rft:
3.5 ?JT, ^ ^ H f e T T ^ ^ t ^ ^ ^ < 1 J l y^l 'MM^^7T^^3TM^Tf^fWt^t
qR^H ^ t 30 t^T ^ t 3 r f l % "^kT 3F5JTTFT TTTfwft ^ f>feT T̂ T *f ^RT
24-^7 % <wfa*m (3) % 7 ^ (ii) f̂ ^nf^FTfe T f ^ t ^ n i x^q- % T̂TeT 1i«T^
3.6 faPwIdl m *qR?T if 377^ ^ f ^ f 37feclt W # R ^ R ^ [ WM|um̂ ^ 7f#^T
26 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
%'ft^T ^ %̂TTT, fa^ TOk ^RTT ̂ 48 ^ ^ ^ F T T ^ "T 3Tfafa ^ F̂ FTT
3.7 FT ̂ T Sffafwr 3#T ^T tetff % 3TCk T&ft 3fa STTSTT̂Tf ^T, ~$Z ^ t Ft ^
faf^rfar ^R*RT # TF&T ̂ ^ afa 3 ^ r fa^tenr ̂ R3" ^ F r r t ^ M t f r c r l ^ f t
3.9 FT 3 ^ | i M TTTteRTm m^b i.H\ ^TftfatT Mlfa<£d ^ f ^ f t ^ T % ^ t 3 i ^ i m
yifti*i-0 3iicj^+- ̂ r̂nrr T̂TTT eft TRTOT, fe^r -^ ̂ rNr % inn; ̂ #r?r 3fh^pft
% ^T^ r ^ ^ t 3T̂5TT ̂ t I
kjfdTldl %F̂ TTSTT
iJ£T/WT
[*rmil—•qpjg3(i)] MTRT^ITrTW : 3^mK°l 27
3FR£^(H)
(fow 21 ft) 3̂ 7f̂ TTT 24 (^) ^#)
fa>*fl faPwldl ^T 3?T%1JTf*If?T a t f w t f £RT ^T^T *f l^tR 3rfafcITctfnfllid41/fofa 3fq?T
% 3TFTIcT % fat* ^ ^ I c h ^ l % faff 3TT^r % TR^T % TIFT TR?]7T foff ^ % faff
stffacT ^ W * l ( i A R ^ ^ i jp4d ^ T ^ *TCT ^Trr^ 3}R ̂ T^?T ^ t - ^ M + K I ^ ^ T Tp^T f̂t
l. Trmrcw
1.1 3 T h f ? T ^ [ d f t r d / W ^ 3c*TK ^T ^TR, ^ff^T^" fa^T 3#T c^ k l fa iot ik cpf
1.2 arfafo *ft Pcto w infffrfa ^=T for % fctfH4iH<fr Tnfatfrifiqf -gpi ^XT\
TgRfaftmum affair i&Ffoc3Fn$?Rmum (i\^f ff})/3Rr -^m
1,3 ^ W ̂ t ̂ ^ f a t 3fmfa % faff 3Tfafa ITT^T T J ^ T f " P W : ^ T
WfacT)l
1 A fa*g- ^ r ^ r Tm^r ^ F M 3 ^ft ffff Tft «MI»IM^ ^ ^ r ̂ T % TT^T
fafailWeb TTlfasprft SRT ^TT> teT W ^ R k 3?ffM ^T M-MllJIM=4 (7ft it
it) (-H^^hd: ?fer ymfrid)
1.5 3=T ^ f f ^ t cfRT^ % TIW ^Efr, ^ t ^FT 3?fafa % faff fclM«M I j r f W T
3FT^T 3TTCTcT ^R# ^ t 3FprfcT W T ^ t i f f , ( ~ ^ m t ^T?WT ^T T f a ^
t^TT^nffnT)i
1.6 ^ ^ ^ T T R ^ % T n ^ ^ , ^ ^ ^ 3 T ^ T % f a f f rclMi'H^^RrWT
1.7 -^ ^ f f ^ t TTfrfe % T M Tj^t, ̂ f ^ r r sfmfa % faff fawr tfrfw7-
Wm 37PTTcT ̂ ^ t SFjqfr ̂ f ^T 11
1.8 ^^I^fITf3##J^M^I
1.9 3 H ^ f f ^ ^-41 ^ g | 33cT s f a f a ^ Qid M l W 1 1
2. 3#^T^^TraFTf^3^^fkT]^RT
Q̂ d ^d^ ^T^t ^ f t * HIM, ^T^ t i £
28 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
2.2 ^ i * ̂ r -W^M ̂ fhr̂ T r̂ uti<M
shrê f % ̂ 3̂ 7 fasEpf) ̂ arm f̂e*r wi" (wtf) *# ̂ ft i
2.3 i lqfa* pi^d ^f^r "^flf^r 3TtT Plfc$M 3ra*ra (SRtRf) % faP$¥l I
2.4 7#^37^7^(3TcR^f)^r^trT,^FT#TtTrTT
2.5 ^?^3T^T^(3^^f)^tq^lH%Rd4M^^T
37 ĉTT3Tf % W f TTH f̂ % WT 3TC5̂ T ̂ t ^M^l % fair ^T% fWr"r
2.7 i^f ^ r ^ <f^>M"i wfimft SRT ̂ i ^ lRd ^ r ^fer r̂ctf 3 ^ T
2.8 ^ftcf f̂ RcTT 3qk c|| WJ^cb ^T3" R̂ RcTT fa^u'l T̂%cT R̂ RcTT 3RTI
2.9 ^ s t F R T ^ y ^ ^ l
2.11 3rmî f 3^T(ic|cbHlf%^R^r<;wi^i
2.12 ^U^K'JI fMd^T^ry^Hi
2.13 ^ r n-nimM=fl" % m afrrafc Hĉ KfAsfcrfa % # T ̂ afa sn# W5WI
[i^rn—^pg3(i)3 MTO ÎTTTW : 3 W W I 29
rqi^Mdl%^ftH,^^Ht'ST^3^U<uflt'l
2.15 $Mk sik S^FT ^prrft fwr, 1945 % 3T̂ TTT ̂ rip #ap?r ̂ Fitf 3ft
2.16 ^5T ^fat^i i
2.17 3ft#r%"*j#ffiW7^Trf?f^^sfai
<JxlHUJ
3.1 W t t e r ^ m i l l ^ T T f ^ t r ^ ^ P i i l ^ " ! 1 ^ ^ , ^ F T F J ^ I
3.2 3T?KT-̂ lt|î ^cW ( ^ i)J3^S) 4 ^ K T ^ f a ^ ^ ^ f fa W TTfl^T, *lft
3.3 uRt^d faliMiUl a ^ K l ^ f ^ T T T T T T ^ l H ^ u i 1 ^ ^ , i f t ( f P ^ I
3.4 37t^T^^fe^THNcblUdl ^T MR«hd "3c*KJ" ̂ T FTTter, 4|ft <HHĴ I
3.5 ft* wt>̂ »! r̂fter̂ , ̂ ? n ^ , OT^ faPi^i 3fa ylditbM i
3.6 MN-O^^TT^, ^ T ^ ^ , ^ t f fcifa î sftrykHMi
3.7 rfk 3#T ^ T cftcT iW<Mdl ^T^ r , ^ HPt & 3 ^ f RlP^I # ?
3.8 -̂d<-M**T<TT -Bl̂ zr̂ T 3 # 7 ^ djtr*lf<*> T̂£T, ^HP^St1 I
3.10 ^•7ITi^%3T#T37^r^TcT^ld|li|
3^TK % P w * w m *#, 3it#r % faftre; aftr WTPT *)«M^I %rft^ *spft
30 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
<{W«fr|gfl*< i^mqddl 3T^FHf iTT 3TrTT" ^ Tr̂ 7 f̂fe ^qy ^HT 11 3Tfafa % TF>FR
5. ^^iPi* Û «M
afNff̂ T 3JTT TTCn*H TWT, 1945 % ftspq- 122-^ % 3T#T 4«imfymfad f̂ RTT ^ t
sfafa % fair, 5*T% <fcl*jl<=Mul ^ TT^ 3 ^ f^riff % T̂=HT 122-^T % aHfa 3^flNH
ITrfWTt 5RT 3Tr̂ f ^ 3 1 ^ 1 JTM ^ ^ t 3TT^F*KTT t l T f̂t ^ 3Th^T ^ ^T%
<P^cH"i mm* % %TT 3^r toff % 122-37 % 3?^k spjufr % w* WH*~
6. ^N^FTartr^f^nT^HT
6.1 ^^3T^3fhr^n^rwtnjttoT, 1945 % 3T#T fafa&ff % 3TJ^T
6.2 ^%5T ^fo&T 3TM 3 #TT ^T%tr aqfr ^ f tofafecT fcfefa ^%cT
3fl^^llH^)3ff7TPfW^Ttf?TI
VlPrl̂ H 'H*4»d<+> I
3PT 3J\m ?fo!ff % WT 3T^M^TT 3fa 3 T ^ W ^ T T % 3 ^ T ^ r i
TpqfaR 3TTT^RWl; ^ # T ^ T f a f o c # T # ? T M l
T?## ^ *RFT 3#r ^T^T T̂ rfr ^ ^t ̂ m r ̂ r m ^ yf^n
3fen^T % far* trf?T^R^ I
6.3 ^ w T ^ 5 l ^ H ^ PHHrHrWd 3f^4k"^RTTI#TcT &j[ T\\%V :-
[MPT II—^5P^3(i)] MTOTTETTram : <mBI*IHU| 31.
7- fc^ta sdrMKl %1rW 3T^frT fafafe ^TM|
SlfaeR" SppTH m ^ R t ^ t ^TcT teT T̂RT t 3f#T cTH f^T ^ t
2. ?W WTT 4 3#T ^ T WIT 5 ^ wtfm ^RT *TRcfk ^ T ^ 3
3f̂ i%?r artaM3rk^TT^tft, ^tft, ^ttft^ df̂ Hfyd 3?>iM
% fair *ft W\^it t ^ i^fr 3fft#^ft t$t sfafa sftrSWFTWnft
fWT%fWT 122 ^7122 i f 122 TT 122 ^ % 3^TH 3TT#^7 %
fair qRcT ^ fostf" % fcTTi T ^ ^t 37^iTfe teT W ^ I
T3tT cJcMKl % fori 3T^fcT fafw "^RTI
32 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
fad) drMK qftTEiygrTTT PiHEriQad ̂ gifaT^Trrrt:-
^ifacT p̂n%riT afar M w n r T̂%CT, *zfRlf % ̂ 3 3 # ^rs^r ($I$MI$<0
^T^TRrt'l
4. tf q p ^ 3P4,J| ^ ^ , 3TT# ̂ WPt fa^VH afl^T frft-IW^H % ^
6. fore Tr^Fr ^m1<;jf % fcrq a^^pr ^ ^ fefaM ^k fore ^teffa
Wfe *$8>P\ ArnfteT % fafa^ft ^ t ^f§TtT ^R^ §1* 3FtI^cWcfcT«Nt%
7. tarw^afa^&wi
^ T c T 3*ITr^T, W n f t f^ROT, $fa ftWT, MHM<)**"I, f̂ TTrTT SP^FH,
tfa*TT# ^r ^?qK vx$& 4 "p^r ̂ r tf -^m tot ^mT T̂%TT I
[w\ 11— "gr^ 3(i)] "TroysE! w r a : an*<mH»i
sferw a^prw srrfw^ ̂ f̂acr ferr ̂ TRT t f̂hr 30 f^ff ^t
teft sJrMK ^ft W$M *J? PiHlc^naH Wl\m "3TFTT t >
fafcwid! ^RTf^rr^ ^H^iVld l , faiWdl 3#r f^TT 3}WFff ^ t
5, ^3TT^R3^TT^r^fr jH7|
2(.4') C;i/2III)1—5
34 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)1
6. T̂K" -MBÎ I (Wt)
^T^fe^i^iH'i, fa&Mito ̂ if^r sffry ŝH 3*U MRcjrln siftHH 3^#im
Tdiwfl" ̂ ^prrf tor ^mr 13ttr 3 o far ̂ ^w-3T^%,»te3:Fp7^3#r^M^t
[•HFTII—^5pJg3(i)] MTOT *BT WW : araMTT 35
7. ^-3TT^TT3tRT?f^rT r i i |HI !
8 . "^TTT ! l f « ^ l I
9. 3^PT % ?̂T % TTT^T ^FTFRT T#T^R> SRT ~w!t fa^T W, :T^TT #rT
10. Tjg- ̂ (facf, ?[F .^|[-R, 3 } f ^ f ^R TO7T fiRwf faninP^i ^fuifHrl t -\
^ # F T P^fJ, TJtmt f W T , $1" faWT7 TTfeT fawt, fr̂ TrTT 3WFT,
36 THE GAZETTE OF INDIA : EXTRAORDINARV [PART II—SEC. 3(i)J
'|ctfH>-IMI%FFn$F
f^Tr#rr, fafa^rk TTT%̂T f̂tr y ^ r $ ̂ nf̂ cm ^F^HH a^pm
37fwr?T cfrFTt 11
2. 3f(#r #r ^n^rr *rrarft fwr, 1945 % twr 21 % smfr a^lftd
^ M % ^ f a ^ + ^ l yq|u|q^ % -3Frrfr ^ ^ Y^ ^" ^ ^ " ^ ^ ^
[m. *F. •q^T.-1l014/8/2000-^T^TT^HT^1^T^^]
H14 Him"! • TJ7^f^W2#-RT5^"HWJTT^28-10/45-T^(I)ft^FP21 ft*lW, 1945 £KI W * K 1 TT^m ̂ H<*iR;m %TT-TTJ »>
3fa 3Tf^T -mft^ ^T.^.fT. "?T. 242(3T)1^F 3-4-2001 % TCTff f<m\ F̂TT "4TI
[•mn II—tBrog 3(i)2 HTOT m w r e : vmwm 37
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health)
NOTIFICATION
New Delhi, the 24th August, 2001
G.S.R. 604(E).—Whereas a draft of certain rules further to amend the
Drugs and Cosmetics Rules, 1945, were published as required by sections 12 and 33 of
the Drugs and Cosmetics Act, 1940 (23 of 1940), in the Gazette of India, Extraordinary
Tart I I , Section 3, Sub-section (1), dated the 24th October, 2000 under the notification
of the Government of India, in the Ministry of Health and Family Welfare (Department
of Health), No. GSR 834 (E), dated the 24th October, 2000, inviting objections and
suggestions from all persons likely to be affected thereby, before the expiry of a period
of forty-five days £rom the date on which the copies of the Official Gazette containing
the said notification, were made available to the public;
And, whereas copies of the said Official Gazette were made available to the
public on the 25th October, 2000;
And, whereas objections and suggestions received from the public on the said
draft rules have been considered by the Central Government;
Now, therefore, in exercise of the powers conferred by sections 12 and 33 of the
said Act, the Central Government, after consultation with Drugs Technical Advisory
Board, hereby makes the following rules further to amend the Drugs and Cosmetics
Rules, 1945, namely: -
1. (1) These rules may be called the Drugs and Cosmetics
(S'M Amendment)Rules, 2001.
(2) They shall come into force on the l'1 January, 2003.
38 THE GAZETTE OF INDIA ; EXTRAORDINARY [PART II—SEC. 3(i)]
2. In the Drugs and Cosmetics Rules, 1945, (hereinafter referred to as the said rules), in
Part IV, for the heading "IMPORT", the heading " IMPORT AND REGISTRATION"
shall be substituted.
3. In rule 21 of the said rules, -
(i) in clause (a), the words, letters, brackets and figures "specified in Schedules C and
C(I)" shall be omitted,
(ii) after clause (c), the following clauses shall be inserted, namely:-
'(d) "manufacturer", includes a manufacturer of drugs, who may be a Company or a
unit or a body corporate or any other establishment in a country other than India, having
its drugs manufacturing facilities duly approved by the National Regulatory Authority
of that country, and who also has a free sale approval of the drugs approved by the said
authority in the concerned country, and/or in other major countries;
(e) "Registration Certificate" means a certificate issued under rule 27A by the licensing
authority in Form 41 for registration of the premises and the drugs manufactured by the
manufacturer meant for import into and use in India'.
4. In rule 22 of the said rules, for the words, "power to sign licences and", the words,
"power to sign licences and Registration Certificates and" shall be substituted;
[VPTII—75Prg3(i)] HKfl ''FT {WW : <3TOP*RW 39
5. In rule 23 of the said rules, for the words "import of any biological or other special
product specified in Schedule C or C(I)", the words "import of drugs" shall be
substituted.
6. For rule 24 of the said rules, the following rule shall be substituted, namely:-
"24. Form and manner of application for import licence - (1) An application
for an import licence shall be made to the licensing authority in Form 8 for drugs
excluding those specified in Schedule X, and in Form 8-A for drugs specified in
Schedule X, either by the manufacturer himself having a valid wholesale licence for
sale or distribution of drugs under these rules, or by the manufacturer's agent in India
either having a valid licence under the rules to manufacture for sale of a drug or having
a valid wholesale licence for sale or distribution of drugs under these rules, and shall
be accompanied by a licence fee of one thousand rupees for a single drug and an
additional fee at the rate of one hundred rupees for each additional drug and by an
undertaking in Form 9 duly signed by or on behalf of the manufacturer:
Provided that in the case of any subsequent application made by the same
importer for import licence for drugs manufactured by the same manufacturer, the fee to
accompany each such application shall be one hundred rupees for each drug.
(2) Any application for import licence in Form 8 or Form 8-A, as the case may be, shall be
accompanied by a copy of Registration Certificate issued in Form 41 under rule 27-A:
40 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—Sue. 3(i)1
Provided that in case of emergencies the licensing authority may, with the
approval of the Central Government, issue an import licence in Form 10 or 10-A, as the
case may be, without the issuance of Registration Certificate under rule 27-A, for
reasons to be recorded in writing."
(3) A fee of two hundred and fifty rupees shall be paid for a duplicate copy of the
licence issued under this rule, if the original is defaced, damaged or lost.
7. After rule 24 of the said rule, the following rules shall be inserted, namely:-
"24-A. Form and manner of application for Registration Certificate.-
(1) An application for issue of a Registration Certificate shall be made to the licensing
authority in Form 40, either by the manufacturer himself, having a valid whole sale licence for
sale or distribution of drugs under these rules, or by his authorised agent in India, either having
a valid licence under the rules to manufacture for sale of a drug or having a valid whole sale
licence for sale or distribution of drugs under these rules, and shall be accompanied by the fee
specified in sub-rule (3) and the informations and undertakings specified in Schedules D-I and
D-II duly signed by or on behalf of the manufacturer.
(2) The authorisation by a manufacturer to his agent in India shall be documented by a
power of attorney executed and authenticated either in India before a First Class Magistrate, or
in the country of origin before such an equivalent authority, the certificate of which is attested
by the Indian Embassy of the said country, and the original of the same shall be furnished
alongwith the application for Registration Certificate.
[MPT II—"gpig 3 ( i ) ] MRff ^>ITTSPT* : -i>WI*IKul 41^
(3) (i) A fee of one thousand and five hundred US dollars shall be paid
alongwith the application in Form 40 as registration fee for his premises meant
for manufacturing of drugs intended for import into and use in India.
(ii) A fee of one thousand US dollars shall be paid alongwith the
application in Form 40 for the registration of a single drug meant for import into
and use in India and an additional fee at the rate of one thousand US dollars for
each additional drug:
Provided that in the case of any subsequent application for registration of
additional drugs by the same manufacturer, the fee to accompany shall be one
thousand US dollars for each drug.
(4) The fees shall be paid through a Challan in the Bank of Baroda, Kasturba Gandhi
Marg, New Delhi-110 001 or any other branch or branches of Bank of Baroda,
or any other bank, as notified, from time to time, by the Central Government, to
be credited under the Head of Account "0210-Medical and Public Health, 04-
Public Health, 104- Fees and Fines":
Provided that in the case of any direct payment of fees by a manufacturer
in the country of origin, the fees shall be paid through Electronic Clearance
System (ECS) from any bank in the country of origin to the Bank of Baroda,
Kasturba Gandhi Marg, New Delhi, through the Electronic Code of the bank in
the Head of Account "0210-Medical and Public Health, 04-PubIic Health, 104-
Fee and Fines", and the original receipt of the said transfer shall be treated as an
equivalent to the bank challan, subject to the approval by the Bank of Baroda that
they have received the payment."
2649 GI/2001—f,
42 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
(5) The applicant shall be liable for the payment of a fee of five thousand US dollars for
expenditure as may be required for inspection or visit of the manufacturing premises or drugs,
by the licensing authority or by any other persons to whom powers have been delegated in this
behalf by the licensing authority under rule 22:
(6) The applicant shall be liable for the payment of testing fees directly to a testing laboratory
approved by the Central Government in India or abroad, as may be required for examination,
tests and analysis of drug.
(7) A fee of three hundred US dollars shall be paid for a duplicate copy of the Registration
Certificate, if the original is defaced, damaged or lost."
(8) No Registration Certificate shall be required under these rules in respect of an inactive bulk
substance to be used for a drug formulation, with or without pharmacopeal conformity."
8. In rule 25-A of the said rules, in sub-rule (1), in the provisio in clause (b), for sub-clause (i), the
following shall be substituted, namely:-
"(i) his conviction under the Act or these rules or the Narcotic Drugs and Psychotropic
Substances Act, 1985 (61 of 1985) or the rules made thereunder".
[*TPTII—T5T"g3(i)] VRfl *FT O^MS : 31tflt|KU| 43
(9) After rule 25-A of the said rules, the following rule shall be inserted, namely >
"25-B. Registration Certificate for import of drugs manufactured by one
manufacturer.^ 1) A single application may be made, and a single Registration
Certificate in Form 41 may be issued in respect of the import of more than one drug or
class of drugs, manufactured by the same manufacturer:
Provided that the drug or classes of drugs, are manufactured at one factory or more than
one factory functioning conjointly as a single manufacturing unit;
Provided further that if a single manufacturer has two or more factories situated in
different places manufacturing the same or different drugs, separate Registration
Certificates shall be required in respect of the drugs manufactured by each such
factory,"
10. After rule 27 of the said rules, the following rule shall be inserted, namely: -
" 27-A Grant of Registration Certificate:- (1) On receipt of an application for
Registration Certificate in the Form and manner specified in rule 24-A, the licensing
authority shall, on being satisfied, that, if granted, the conditions of the Registration
Certificate will be observed, issue a Registration Certificate in Form 41:
44 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
Provided further that if the application is complete in all respects and informations
specified in Schedules D-l and D-II are in order, the licensing authority shall, within
nine months from the date of receipt of an application, issue such Registration
Certificate, and in exceptional circumstances and for reasons to be recorded in writing,
the Registration Certificate may be issued within such extended period, not exceeding
three months as the licensing authority, may deem fit.
(2) If the applicant does not receive the Registration Certificate within the period as
specified in provisio to sub rule (1), he may appeal to the Central Government and the
Central Government may after such enquire into the matter, as it considers necessary,
may pass such orders in relation thereto as it thinks fit."
In rule 28 of the said rules, for the words, figures and letters, "valid up to the 31* December of
the year following the year in which it is granted", the words "valid for a period of three years
from the date of its issue" shall be substituted.
After rule 28 of the said rules, the following rule shall be inserted, namely:-
"28-A. Duration of Registration Certificate.-A Registration Certificate, unless, it is sooner
suspended or cancelled, shall be valid for a period of three years from the date of its issue:
Provided that if the application for a fresh Registration Certificate is made nine months
before the expiry of the existing certificate, the current Registration Certificate shall be deemed
to continue in force until orders are passed on the application".
[MFTH—-gprE3(i)] *TTOT̂ T W T S : -4miHK«l 45
13. In rule 29 of the said rules, for the proviso, the following proviso shall be
substituted, namely:-
"Provided that a person who is aggrieved by the order passed by
the licensing authority under this rule may, within thirty days of the receipt of the
order, appeal to the Central Government, and the Central Government may, after
such enquiry into the matter, as it considers necessary and after giving the said
appellant an opportunity for representing his views, pass such orders in relation
thereto as it thinks fit."
14. After rule 29 of the said rules, the following rule shall be inserted, namely:-
"29-A. Suspension and cancellation of Registration Certificate.- If the
manufacturer fails to comply with any of the conditions of the Registration
Certificate, the licensing authority may after giving him an opportunity to
show cause why such an order should not be passed, by an order in writing
stating the reasons therefor, suspend or cancel the Registration Certificate
for such period as it thinks fit either wholly or in respect of some of the
substances to which it relates:
Provided that a person, who is aggrieved by the order passed by
the licensing authority under this rule may, within thirty days of the
receipt of the order, appeal to the Central Government, and the Central
Government may, after such enquiry into the matter as it considers
necessary and after giving the appellant an opportunity for representing his
views in the mailer, pass such orders in relation thereto as it thinks fit".
46 THE GAZETTE OF INDIA : EXTRAORDINARY [PART 11—She. 3(i)]
15. For rule 31 of the said rules, the following rule shall be substituted
namely.-
"31. Standard for certain imported drugs.-No drug shall be imported
unless it complies with the standard of strength, quality and purity, if any,
and the test prescribed in the rules shall be applicable for determining
whether any such imported drug complies with the said standards:
Provided that the drugs intended for veterinary use, the standards of
strength, quality and purity, if any, shall be those that are specified in
Schedule F(l) and the test prescribed in that Schedule shall be applicable
for determining whether any such imported drug complies with the said
standards and where no standards are specified in Schedule F(l) for any
veterinary drug, the standards for such drug shall be those specified in the
current edition, for the time being in force, of the British Pharmacopoeia
Veterinary:
Provided further that the licensing authority shall not allow the
import of any drug having less than sixty per cent, residual shelf-life
period as on the date of import:
Provided also that in exceptional cases the licencing authority may,
for reasons to be recorded in writing, may allow, the import of any drug
having lesser shelf-life period, but before the date of expiry as declared on
the container of the drug."
[MPTU—•CTfrg3(i)] MKTT m Trem : 3W raK1"! 47
- J . l -
16. «After rule 33 of the said rules, the following rule shall Be inserted,
namely:-
"33-A. Import of drugs by a Government Hospital or
Autonomous Medical Institution for the treatment of patients.- Small
quantities of a new drug, as defined in rule 122-E, the import of which is
otherwise prohibited under section 10 of the Act, may be imported for
treatment of patients suffering from life threatening diseases, or diseases
causing serious permanent disability, or such disease requiring therapies
for unmet medical needs, by a Medical Officer of a Government Hospital
or an Autonomous Medical Institution providing tertiary care, duly
certified by the Medical Superintendent of the Government Hospital, or
Head of the Autonomous Medical Institution, subject to the following
conditions, namely:-
(a) no new drug shall be imported for the said purpose except
under a licence in Form 11-A, and the said drug has been
approved for marketing in the country of origin;
(b) the licencee shall use the substances or drugs imported
under the licence exclusively for the purpose of treatment
of patients suffering from life threatening diseases, or
diseases causing serious permanent disability, or such
diseases requiring therapies for unmet medical needs,
under the supervision of its own Medical Officers at the
place, specified in the licence or at such other places, as the
licensing authority, may from time to time authorise;
48 THE GAZETTE OF INDIA : EXTRAORDINARY [PART H—SEC. 3(i)]
(c) the licencee shall allow an Inspector authorised by the
licensing authority in this behalf to enter, with or without
prior notice, the premises where the substances or drugs are
stocked, and to inspect the premises and relevant records
and investigate the manner in which the substances or
drugs are being used and to take, if necessary, samples
thereof;
(d) the licencee shall keep a record of, and shall submit the said
report half yearly to the licensing authority, the substances
or drugs imported under the licence, together with the
quantities imported and issued to the patients, the date of
importation, the name of the manufacturer, the name and
address of the patient for whom the drug is prescribed and
the name of disease;
(e) the licencee shall comply with such other requirements, if
any, applicable to the holders of import licences for import
of new drugs for treatment of patients by Government
Hospitals, as may be specified from time to time in any rule
subsequently made under Chapter III of the Act and of
which the licensing authority has given to him not less than
one month's notice;
[ i p i n - •qr*g3(i)] r̂or W W T S : 3raraRnr 49
(f) the drug shall be stocked under proper storage conditions and shall be
dispensed under the supervision of a registered pharmacist;
(g) the quantity of any single drug so imported shall not exceed 100 average
dosages per patient:
Provided that the licensing authority may, in exceptional circumstances,
sanction the import of drug a larger quantity."
17. In rule 34 of the said rules, for sub-rule (3), the following, shall be substituted, namely:-
'(3) Every application in Form 12 shall be accompanied by a fee of one hundred
rupees for a single drug and an additional fee of fifty rupees for each additional
drug.
(4) The fees shall be paid through a challan in the Bank of Baroda, Kasturba
Gandhi Marg, New Delhi-110 001 or any other branch or branches of Bank of
Baroda, or any other Bank, as Notified, from time to time, by the Central
Government, to be credited under the Head of Account "0210-Medical and
Public Health, 04~Public Health, 104-Fees and Fine".'
Z649 G1/2001—7
50 . .THE GAZETTE OF INDIA ; EXTRAORDINARY [PART II—SEC. 3(i)]
18. After rule 34 of the said rules, the following shall be inserted, namely:-
'34-A. Application for licence to import small quantities of new drugs by a
Government Hospital or Autonomous Medical Institution for the treatment
of patients.- (1) An application for an import licence for small quantities of a
new drug, as defined in rule 122-E for the purpose of treatment of patients
suffering from life threatening diseases, or diseases causing serious permanent
disability, or such diseases requiring therapies for unmet medical needs, shall be
made in Form 12-AA, by a Medical Officer of the Government Hospital or
Autonomous Medical Institution, which shall be certified by the Medical
Superintendent of the Government Hospital or Head of the Autonomous
Medical Institution, as the case may be.
(2) The licensing authority may require such further particulars to be
supplied, as he may consider necessary.
(3) Every application in Form 12-AA shall be accompanied by a fee of one
hundred rupees for a single drug and an additional fee of fifty rupees for each
additional drug.
(3) The fees shall be paid through a challan in the Bank of Baroda, Kasturba
Gandhi Marg, New Delhi-110 001 or any other branch or branches of Bank
of Baroda, or any other Bank, as Notified, from time to time, by the Central
Government, to be credited under the Head of Account "0210-Medical and
Public Health, 04-Public Health, 104-Fees and Fine".'
[•HPT II—~gprg3(i)] *flTtt ŜT IWW : ^WWR"! 51
19. After rule 35 of the said rules, the following rule shall be inserted, namely:-
"35-A. Cancellation of licence for import of small quantities of
new drugs.- (1) A licence for import of small quantities of a new
drug, defined in rule 122-E, for the purpose of the treatment of
patients suffering from life threatening diseases, or diseases
causing serious permanent disability, or such diseases requiring
therapies for unmet medical needs, by a Government Hospital or
an Autonomous Medical Institution may be cancelled by the
licensing authority for breach of any of the conditions subject to
whiGh the licence was Issued or for contravention of any of the
provisions of the Act and rules made thereunder.
(2) A licencee whose licence has been cancelled may appeal to
the Central Government within three months from the date of the
receipt of the order, and the Central Government may after such
enquiry into the matter, as it considers necessary and after giving
the appellant an opportunity for representing his views, may pass
such orders in relation thereto, as it thinks fit."
52 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
20. In Schedule A to the said rules,-
(a) for Form 8, the following Form shall be substituted, namely:-
'FORM 8
(See rule 24)
Application Tor licence to Import drugs (excluding those specified in Schedule X) to the Drugs and
Cosmetics Rules, 1945.
I / we , (full address
with telephone number, fax number and e-mail address) hereby apply for a
licence to import drugs specified below manufactured by M/s
(full address with telephone no, fax
and e-mail no.)
2. Names of the drugs to be imported:
(1)
(2)
(3)
3 1/we ^ _ ^ enclose
herewith an undertaking in Form 9 dated __________ signed by the
manufacturer as required by rule 24 of the Drugs and Cosmetics Rules,
1945.
[«TFTII—qr*g3(i)] HOT ^T ^ H I : -HWIWI 53
Place:
Date:
I/we enclose herewith a copy
of Registration Certificate concerning the drugs to be imported in India, issued under
Form 41 of the rules, vide Registration Certificate No Dated
issued through
M/s (name and full address
valid upto
I/we hold a valid wholesale
licence for sale or distribution of drugs or valid licence to manufacture drugs, under the
provisions of the Act and rules made thereunder. A copy of the said licence is
enclosed.
A fee of has been credited to Government under the Head of Account
"0210 - Medical and Public Health, 04- Public Health, 104- Fees and Fines" under the
Drugs and Cosmetics Rules, 1945 - Central vide Challan No. , dated
(attached
in original).
Signature
Name
Designation
Seal/Stamp of Manufacturer's agent in India
delete whichever is not applicable;'
54 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(Q]
(a) for Form 8-A, the following Form shall be substituted, namely:-
'FORM 8-A
(Sec rule 24)
Application Tor licence to Import drugs specified In Schedule X to the Drugs and Cosmetics Rules, 1945.
I / we , (full address
with telephone number, fax number and e-mail address) hereby apply for a
licence to import drugs specified below manufactured by M/s
(full address with telephone no, fax
and e-mail no.)
2. Names of the drugs to be imported:
(1)
(2)
(3)
3 1/we enclose
herewith an undertaking in Form 9 dated signed by the
manufacturer as required by rule 24 of the Drugs and Cosmetics Rules,
1945.
4. I/we enclose
herewith a copy of Registration Certificate concerning the drugs to be
imported in India issued under Form 41 of the rules, vide Registration
Certificate No Dated issued through
M/s (name and
full address valid
uplo .
Place:
Date:
5. I/we hold a
valid wholesale licence for sale or distribution of drugs or licence to
manufacture drugs,. under the provisions of the Act and rules made
thereunder. A copy of the said licence is enclosed.
6. A fee of has been credited to Government under the
Head of Account "0210 - Medical and Public Health, 04- Public Health,
104- Fees and Fines" under the Drugs and Cosmetics Rules, 1945 -
Central vide Challan No. dated (attached in
original).
Signature
Name
Designation
Seal/Stamp of Manufacturer's agent in India
delete whichever is not applicable.'
56 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)1
(c) in Form 9, in the end, for the words "Signed by or on behalf of the
manufacturer," the words "Signature, Name, Designation, Seal/Stamp of
manufacturer or on behalf of the manufacturer" shall be substituted;
(d) for Form-10, the following Form shall be substituted, namely:-
"FORM 10
(See rules 23 and 27)
Licence to import drugs (excluding those specified in Schedule X) to the Drugs and
Cosmetic Rules, 1945
Licence Number Date
(Name
and full address of the importer)
is hereby licenced to import into India during the period for which this licence is
in force, the drugs specified below, manufactured by M/s
(name and full address) and any
other drugs manufactured by the said manufacturer as may from time to time be
endorsed on this licence.
2. This licence shall be in force from
to unless it is sooner suspended or cancelled under the
said rules.
[HPT II—-gp*g3(i)] TO^IWt : 3raraRflT 57
3. Names of drugs to be imported:
Place:
Date : LICENSING AUTHORITY
Seal/Stamp
• delete whichever is not applicable,
Conditions of Licence
1. A photocopy of licence shall be displayed in a prominent place in a part of
the premises, and the original licence shall be produced, whenever
required.
2. Each batch of drug imported into India shall be accompanied with a
detailed batch test report and a batch release certificate, duly signed and
authenticated by the manufacturer with date of testing, date of release and
date of forwarding such reports. The imported batch of each drug shall be
subjected to examination and testing as the licensing authority deems fit
prior to its marketing.
3. The licencee shall be responsible for the business activities of the
manufacturer in India alongwith the registration holder and his authorised
agent.
4 The licencee shall inform the licensing authority forthwith in writing in
the event of any change in the constitution of the firm operating under the
licence. Where any change in the constitution of the firm takes place, the
current licence shall be deemed to be valid for a maximum period of three
months from the date on which the change takes place unless, in the
meantime, a fresh licence has been taken from the licensing authority in
the name of the firm with the changed constitution";
264!) Gf/2001—8
58 THE GAZETTE OF INDIA : EXTRAORDINARY [PARI II—She. 3(i)]
(c) for form 10-A, the following Ironn shall be substituted, namcly:-
4 FORM 10-A
(See rules 23 and 27)
Licence to import drugs specified in Schedule X to the Drugs and Cosmetic Rules,
1945
Licence Number , Dale „ _ _ _
^ . (Name
and full address of the importer)
is hereby licenced to import into India during the period for which this licence is
in force, the drugs specified below, manufactured by M/s
, (name and full address) and any
other drugs manufactured by the said manufacturer as may from time to time be
endorsed on this licence.
2. This licence shall be in force from
to ^ unless it is sooner suspended or cancelled under the
said rules.
3. Names of drugs to be imported:
Place:
Date : LICENSING AUTHORITY
Seal/Stamp
delete whichever is not applicable.
[*nHH—-gp^3(i)] -mxi ^ THN? : 3fqiw"i 59
Conditions of Licence
1. A photocopy of licence shall be displayed in a prominent place in a part of the
premises, and the original licence produced, whenever required.
2. Each batch of drug Imported into India shall be accompanied with a detailed
batch test report and a batch release certificate, duly signed and authenticated
by the manufacturer with dale of testing, date of release and date of
forwarding such reports. The imported batch of each drug shall be subjected
to examination and testing as the licensing authority deems fit prior to its
marketing.
3. The licencee shall be responsible for the business activities of the
manufacturer in India alongwith the registration holder and his authorised
agent.
4. The licencee shall inform the licensing authority forthwith in writing in the
event of any change in the constitution of the firm operating under the licence.
Where any change in the constitution of the firm takes place, the current
licence shall be deemed to be valid for a maximum period of three months
from the date on which the change takes place unless, in the meantime, a fresh
licence has been taken from the licensing authority in the name of the firm
with the changed constitution";
60 THE GAZETTE OF INDIA : EXTRAORDINARY [PARI II—SEC. 3(i)]
(f) allcr Form 1 1, ihc following form shall be inserted namely:-
4FORM 11-A
(Sec rule 33-A)
Licence to import drugs by a Government Hospital or Autonomous Medical
Institution for the treatment of patients
Licence No. Dale
Dr. _________ _ _ _ _ — _ _ _ _ _ „ _ _ _ _ Designation
of
(Name of College/ Ilonpiuil/ Autonomous Institution)
is hereby licenced to import from M/s
(name and full address) the drugs specified below for the purpose of treatment of
patients for the disease (name of the disease) at
_„___^____________________„ or in such other places as the licensing
authority may from time to time authorise,
2. This licence shall, unless previously suspended or revoked, be in force
for a period of one year from the date of issue specified above.
3. Names of drugs to be imported:-
[WTII—•gP^3(i)] MTOT ̂ 1 "WTO : ^H-HI^K«I 61
Names of drug Quantity which may be imported
Place:
Date:.
Seal/Stamp
LICENSING AUTHORITY
Conditions of Licence
The licence shall be displayed in the Office of the Medical
Superintendent of Government Hospital /Head of Institution of
Autonomous Medical Institution.
The licencee shall store the drugs imported under this licence
under proper storage conditions.
The drugs imported under this licence shall be exclusively used for
the treatment of patients, and a record shall be maintained in this
regard, by a registered pharmacist giving the full name(s) and
address (es) of the patients, diagnosis, dosage schedule, total
quantity of drugs imported and issued, and shall be countersigned
by the Medical Superintendent of the Government Hospital or Head
of the Autonomous Medical Institution which shall be produced, on
demand by an Inspector appointed under the Act.
62 THE GAZETTE OF INDIA : EXTRAORDINARY |PART 11—SRC. 3(i)l
(g) in Form 12, for the second paragraph, the following shall be substituted,
namely:-
'A fee of rupees
has been credited to Government under the Head of Account " 0210-
Medical and Public Health, 04-Public Health, 104- Fees and Fines under
the Drugs and Cosmetics Rules, 1945 - Central vide Challan
No. . Dated (attached in original).'
(h) after Form 12-/Y, the following Form shall be inserted, namely:-
'FORM 12-AA
(See rule 34A)
Application for licence to import small quantities of new drugs by a
Government Hospital or Autonomous Medical Institution for the treatment
of patients.
I, (name and designation) __________
of (name of the
Hospital/Autonomous Medical Institution)
hereby apply for a licence to import small quantities of new drugs specified
below for the purpose of treatment of patients for the disease
(name of the disease) at
___ _ _ _ _ _ „ ________„ (name and place of the
hospital) and I undertake to comply with the conditions applicable to the licence
and other provisions of the Drugs and Cosmetics Act , 1940 and the rules made
thereunder, from time to time.
[MFT1I—~~? 3(i)] m$ ^T mw •. aromn- 63
1. A fee of lupees has been credited to Government under the Head
of Account "0210- Medical and Public Health, 04- Medical and Public Health, 104-
Fees and Fines" under the Drugs and Cosmetics Rules, 1945 - Central vide Challar
No. dated , (attached in original).
2. Name of new drug to be imported-
Name of drug Quantity which may be imported
Place:
Date:
Signature
Name _________________
Seal/Stamp
CERTIFICATE
Certified that the drugs specified above for import are urgently required for the treatment of
patients suffering from and that the said drug(s) is /are not
available in India.
SIGNATURE _ _
Medical Superintendent of the Government Hospital/Head of
Autonomous Medical Institution'
Seal/Stamp,1
PLACE
DATE
64 THF. GAZETTE OF INDIA , I'.XTKAOUmNAkY | i ' \u II S I . - 1 ( I ) |
(i) alter Form 39 the following Forms shall be inscitcd, namely:-
' Form 40
(See rule 24-A )
Application for issue of Registration Certificate for import of drugs into India under the
Drugs and Cosmetics Rules, 1945
I/We
(Name and full
address ) hereby apply for the grant of Registration Certificate to the manufacturer,
M/s (full address with telephone, fax
and E-mail address of the foreign manufacturer) for his premises, and manufactured
drugs meant for import into India.
1. Names of drugs for registration
(1)
(2)
(3)
2. ]/We enclose herewith the informations and undertakings specified in Schedule D (1)
and Schedule D (II) duly signed'by the manufacturer for grant of Registration
Certirtificate for the premises stated below.
3. A fee of „ _ _ _ _ for registration of premises, the particulars of which are
given below, of the manufacturer has been credited to the Government under the Head
of Account "0210-Medical and Public Health, 04-Public Health, 104-Fees and Fines"
under the Drugs and cosmetics Rules, 1945 - Central vide Challan No. __ ,
dated , (attached in original)
[*rm ii—-srng.Hi)] MTOT m iMM^ : 3TOT*nT°r 65
4. A fee of for registration of the drugs for import as
specified at Serial No 2 above has been credited to the Government under
the Head of Account "0210-Mcdical and Public Health, 04-I'ub!ic Health,
104-Fees and Fines" under the Drugs and cosmetics Rules, 1945 - Central
vide Challan No. dated , (attached in original).
5. Particulars of premises to be registered where manufacture is
carried on:
Address (es) :
Telephone :
Fax :
E- mail :
l/we undertake to comply with all the terms and conditions required to obtain
Registration Certificate and to keep it valid during its validity period,
PLACE:
OATH:
Signature _
Name
Designation
Seal/Stamp of inaiuifactuier or his
aulhoiiscd agent in India
(Note:- In case the applicant is an aulhoiiscd agent of ihe manufactiiier in India, the
Power of Attorney is ID be enclosed)
whichever is not applicable
2(>V) Gl/2001—9
66 THE GAZETTE OF INDIA : EXTRAORDINARY |PART II—SEC. 3(i)l
Form 41
(See rule 27-A)
Registration Certificate
Registration Certificate to be issued for import or dings into India under Drugs and
Cosmetics Rules, 1945.
Registration Certificate No.__ Date
M/s ( Name and full
Address of registered office) „_____„ _ _ _ _ _ _
having factory premises
(full address) has been registered under rule 27-A as a
manufacturer and is hereby issued this Registration Certificate.
2. Name (s) of drugs which may be imported under this Registration
Certificate.
(1)
(2)
(3)
3. This Registration Certificate shall be in force from to
unless it is sooner suspended or cancelled
under the rules.
4. This Registration Certificate is issued through the office of the
manufacturer or his authorised agent in India M/s (name and full address)
who will be responsible for the business activities of the mniuilaclmcr,
in India in all respects.
CTFT II—ws 3(i)] vro TR i\*iw : arararcr 67
5. This Registration Certificate is subject to the conditions, stated below and to such other
conditions as may be specified in the Act and the rules, from time to time.
LICENSING AUTHORITY
Seal/Stamp
Conditions of the Registration Certificate
1. The Registration Certificate shall be displayed at a prominent place by the authorised
agent.
2. No drug shall be registered unless it has a free sale approval in the country of origin,
and/or in other major countries.
3. The manufacturer or his authorised agent in India shall comply with the conditions of
the import licence issued under the Drugs and Cosmetics Rules, 1945.
4. The manufacturer or his authorised agent in India shall inform the licensing authority
forthwith in the event of any administrative action taken due to adverse reaction, viz.
market withdrawal, regulatory restrictions, or cancellation of authorisation, and/or not
of standard quality report of any drug pertaining to this Registration Certificate
declared by the Regulatory Authority of the country of origin or by any Regulatory
Authority of any other country, where the drug is marketed/sold or distributed.
The despatch and marketing of the drug in such cases shall be stopped immediately,
and the licensing authority shall be informed immediately. Further action in respect of
such stopped marketing of drug shall be followed as per the direction of the licensing
authority. In such cases, action equivalent to that taken with reference to the
concerned drug in the country of origin or in the country of marketing shall be followed
in India also, in consultation with the licensing authority. The licensing authority
Place:
Date:
68 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)1
may, however, direct any further modification to this course of action, including the
withdrawal of the drug from Indian market within 48 hours time period.
The manufacturer or his authorised agent in India shall inform the licensing authority
within 30 days in writing in the event of any change in manufacturing process, or in
packaging, or in labeling or in testing, or in documentation of any of the drug pertaining
to this Registration Certificate.
In such cases, where there shall be any major change/modification in manufacturing,
or in processing or in testing, or in documentation as the case may be, at the
discretion of the licensing authority, the manufacturer or his authorised agent in India
shall obtain necessary approval within 30 days by submitting a separate application
alongwith the registration fee, as specified in clause (ii) of sub rule (3) of rule 24-A.
The manufacturer or his authorised agent in India shall inform the licensing authority
immediately in writing in the event of any change in the constitution of the firm and /or
address of the registered office/ factory premises operating under this Registration
Certificate. Where any such change in the constitution of the firm and/or address takes
place, the current Registration Certificate shall be deemed to be valid for a maximum
period of three months from the date on which the change has taken place unless, in
the meantime, a fresh Registration Certificate has been taken from the licensing
authority in the name of the firm with the changed constitution of the firm and/or
changed address of the registered office or factory premises".
[MFTII—-gTO3(i)] •HTTff "W tWIHI : 3TOTWT 69
21. In Scneduje 'D' to the said rules, Sr. No.4 and its entries relating thereto shall be
omitted.
22. After Schedule 'D1 to the said rule, the following Schedules shall be inserted, namely:-
"SCI1EDULE D (1)
(Sec rule 21 (d) and rule 24 A)
Information and undertaking required to be submitted by the manufacturer or his
authorised agent with the Application Form for a Uegistratioii Ccrtincate. The format
shall be properly filled in for each application in Form 40. The detailed information,
secret in nature, may be furnished on a Computer Floppy.
1 Particulars of the manufacturer and manufacturing premises
1.1 Name and address of the manufacturing premises (telephone No, Fax No.E-mail
address) to be registered.
1.2. Name(s) and address(es) of the Proprietor/Partners/Directors.
1.3. Name and address of the authorised Agent in India, responsible for the business of the
manufacturer.
1.4 A brief profile of the manufacturer's business activity, in domestic as well as global
market.
1.5 A copy of Plant Master File (duly notarised)
1.6 A copy of Plant Registration/approval Certificate issued by the Ministry of
Health/National Regulatory Authority of the foreign country concerned(duly notarised)
1.7. A brief profile of the manufacturer's research activity.
70 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC, 3(i)]
2. Particulars of the manufactured drugs to be registered under Registration
Ccrtificate.-
2.1 Names of drugs (Bulk/Formulation/Special product) to be registered meant for
import into and use in India:
2.2 A copy of the approved list showing the bulk drugs/formulations/special
products mentioned in 2.1 above are permitted for manufacturing/marketing in
the country of origin, (duly notarised).
2.3 A copy of Good Manufacturing Practice (GMP) certificate, as per WHO- GMP
guidelines, or Certificate of Pharmaceutical Products (CPP), issued by the
National Regulatory Authority of the foreign country concerned, in relation to
the bulk drugs or formulations or special products, meant for import into India:
2.4 The domestic prices of the drugs to be regisleied in India, in the currency of the
country of origin:
2.5 The name(s) of the drug(s) which are original research products of the
manufacturer,
3. Undertaking to declare tliat:-
3.1 We shall comply with all the conditions imposed on the Registration Certificate,
read with rules 74 and 78 of the Drugs and Cosmetics rules, 1945.
3.2 Wc declare that we are carrying on the manufacture of the drugs mentioned in
this Schedule, at the premises specified above, and we shall Horn time to lime
report any change of premises on which manufacture will be carried on and in
cases where manufacture is canied on in more than one factory any change in
the distribution of functions between the factories:
[^mii—Tsr"g3(i)] MTOI ^ i TTT^ .- ^rararrr 71
3.3 We shail comply with the provisions of Part IX of the Drugs and Cosmetics
Rules, 1945:
3.4 Every drug manufactured by us for import under the Registration Certificate into
India shall be as regard strength, quality and purity conforms with the provisions
of Chapter III of Drugs and Cosmetics Act, 1940 and Part IV of the Drugs and
Cosmetics Rules, 1945, and their amendments from time to time:
3.5 We shall from time to time report for any change or manufacturing process, or
in packaging, or in labeling, or in testing, or in documentation of any of the
drugs, pertaining to the Registration Certificate, to be granted to us. Where any
change in respect of any of the drugs under the Registration Certificate has taken
place, in respect of any of the above matters, we shall inform the same to the
licensing authority, in writing within 30 days from the date of such changes. In
such cases, where there will be any major change/modification in manufacturing
or in processing or in testing, or in documentation, as the case may be, at the
discretion of the licensing authority, we shall obtain necessary approval within
30 days by submitting a separate application, alongwith the registration fee as
specified in clause (ii) of sub rule (3) of rule 24-A.
3.6 We shall from time to time report for any administrative action taken due to
adverse reaction, viz. market withdrawal regulatory restriction, or cancellation
of authorisation and/or " not of standard quality report" of any drug pertaining to
the Registration Certificate declared by any Regulatory Authority of any country
where the drug is marketed/sold or distributed. The despatch and marketing of
the drug in such cases, shall be stopped immediately and the licensing authority
shall be informed immediately. Further action in respect of slop marketing of
drug shall be taken as per the directions of the licensing authority. In such
cases, action equivalent to that taken with reference to the concerned dnig(s) in
the country of origin or in the country of marketing will be followed in India
also, in consultation with the licensing authority. The licensing aulhoiity may
direct any further modification to this course of action, including the withdrawal
of the drug from Indian market within 48 hours time period.
72 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEP. 3(i)1
3.7. We shall comply with such further requirements, if any, as may be specified, by
the Government of India, under the Act and the rules, made thereunder.
3.8 Wc shall allow the licensing authority and/or any person authorised by him in
that behalf to enter and inspect the manufacturing premises and to examine the
process/procedure and documents in respect of any drug manufactured by us for
which the application for Registration Certificate has been made:
3.9 We shall allow the licensing authority or any person authorised by him in that
behalf to take samples of the drugs concerned for test, analysis or examination,
if considered necessary by the licensing authority.
Place;
Date:
Signature of the manufacturer
Seal/Stamp
[MPT II—T5TO3(i)] MTOT ^iT TTSPTT : s raTORT 73
SC11EDULE D(l l )
(Sec rule 21 (d) mid rule 24 A)
Information required lo be subinillcd by the innnurnclurcr or his authorised
agent with the Application Form for the registration of a bulk
drug/formulation/spccial product for its import into India. The format shall
be properly Tilled in and the detailed information, secret in nature, may be
furnished on a Computer Floppy.
1. GENERAL
1.1 Name of the drug/formulation/special product, a brief description and the
therapeutic class to which it belongs.
1.2 Regulatory status of the drug, Free Sale Certificate and/or Certificate of
Pharmaceutical Products (CPP) issued by the Regulatory Authority of the
country of origin. Free sale approval issued by the Regulatory Authorities
of other major countries.
1.3 Drugs Master File (DMF) for the drug to be registered (duly notarised).
1.4 GMP Certificate in WHO formats or Certificate of Pharmaceutical
Products (CPP) issued by National Regulatory Authority of the country of
origin (duly notarised).
1.5 List of countries where marketing authorisation or import permission for
the said drug is granted with dale (respective authorisation shall be
enclosed).
1 6 List of countries where marketing authorisation or import permission for
the said drug is cancelled/withdrawn with date.
1.7 List of countries where marketing authorisation or import permission for
the said drug is pending since (dale).
1.8 Domestic price of the drug in the currency followed in the country of
origin.
1.9 List of countries where the said drug is patented
264V GI72001—10
74 THE GAZETTE OF TNDIA . EXTRAORDINARY [PART II—SEC. 3(i)]
CHEMICAL AND PHARMACEUTICAL INFORMATION OF DRUGS.
2.1 Chemical name
Code name or number, if any
Non-propriclory or generic name, if any
Structure
Physico-chemical properties
2.2 Dosage form and its composition,
Qualitative and Qualitative composition in terms of the active substance(s)
and excipient(s)
List of active substance(s) separately from the constituent(s) of excipients.
2.3 Specifications of active and inactive ingredient(s) including pliarmacopeal
references,
2.4 Source of active ingiedicnt(s), name and address.
2.5 Tests for identification of the active ingredient(s),
Method of its assays and tests for impurity profile with reference standards
for the impurities (Protocol to be submitted alongwith reference standards
for the impurities/relative substances).
2.6 Outline method and flow chart of manufacture of the bulk drug or finished
formulation or special product.
2.7 Detailed test protocol for the drug with pliarmacopeal reference or in
house specification as approved by the registration authority, in the
country of origin.
2.8 Stability data including accelerated stability and real time stability
analysis.
2.9 Documentation on pack size.
2 10 Numerical expression on EAN bar code on the labels and cartons.
[HFTII—-gprg3(i)] *tror^TTnpT7: arormTT 75
2.11 Safety documents on containers and closer.
2.12 Documentation on storage conditions.
2.13 Three samples of medicinal product/drug and outer packaging are to be
submitted with batch certificates. Additional samples as well as reference
substances with batch certificates including date of manufacture, shelf life,
storage conditions of reference substance may be required both during
registration procedure and during validity of registration decision.
2.14 Batch test reports/certificate of five consecutive production batches in
details of the medicinal product are to be submitted for every site of
manufacturing premises,
2.15 Manner of labelling as per rule 96 of the Drugs and Cosmetics Rules,
1945.
2.16 Package insert.
2.17 Details of safety handling procedure of the dtug.
2.18 Details of PMS study report for marketing period not exceeding five years.
76 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
3 BIOLOGICAL AND BIOPHARMACEUTICAL INFORMATION OF
DRVGS.
3.1 Biological control tests applied on the starting material, if applicable.
3.2 Biological control tests applied on the intermediate pioducts, if applicable.
3.3 Biological control tests applied on the finished medical products, if
applicable.
3.4 Stability of the finished products in terms of biological potency of the
drug, if applicable.
3.5 Sterility tests, if applicable, specification and protocol therein.
3.6 Pyrogen tests, if applicable specification and protocol therein.
3.7 Acute and sub-acute toxicity tests, if applicable specification and protocol
therein.
3.8 Bio-availability studies and bio-equivalcnce data, if applicable.
3.9 Data relating to the environmental risk assessment for r-UNA products.
3.10 Other information relevant under the section.
4. PHARMACOLOGICAL AND TOXICOLOGICAL INFORMATION OF
DRUGS
Executive summary of the product is to be submitted mentioning the specific and
general pharmacological actions of the drug and pharmacokinetic studies on
absorption, metabolism, distribution and excretion. A separate note is to be given
on acute and sub-acute toxicity studies and long term toxicity studies. Specific
studies on reproductive toxicity, local toxicity and carcinogenic activity of the
drug is to be elaborated, as far as possible.
[Hm II—T5P^g 3(i)] *1TOT ~^\1JWW : aTOTMKW 77
5. CLINICAL DOCUMENTATION
A new drug as defined under rule 122-E of the Drugs and Cosmetics Rules, 1945
is required to be permitted separately by the licensing authority under rule 122-A
of the said rules prior to its registration, Such a new drug requires a brief
summary on clinical documentation, alongwith permission under 122-A of the
said rules for its Registration Certificate.
6. LABELLING AND PACKAGING INFORMATION OF DRUGS.
6.1 Lables should conform as per the specifications under the Drugs and
Cosmetics Rules, 1945.
6.2 Package insert should be in English and shall indicate the following
therapeutic indications:-
Posology and method of administration.
Contra-indications.
Special warnings and special precautions for use, if any.
Interaction with other medicaments and other forms of intcration,
Pregnancy and lactation, if contra-indicated.
Effects of ability to drive and use machines, if contra-indicated.
Undesirable effects/side effects.
Antidote for overdosing.
6.3 Package insert should indicate the following pharmaceutical information:-
List of excipients.
Incompatibilities,
Shelf life in the medical product as packaged for sale.
Shelf life after dilution or reconstitution according to direction.
78 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)l
Shelf life after first opening the container.
Special precautions for storage.
Nature and specification of the container.
Instructions for use/handling.
7. SPECIFIC INFORMATION REQUIRED FOR THE SPECIAL
PRODUCTS (to be supplied, separately in atinexures, as 'A' , ' B' and 'C \ )
The information submitted above is true to the best of my knowledge and belief.
Place:
Date:
Signature of the manufacturer
Seal/Stamp
NB: 1. Any change in the process of manufacture, method of testing, labeling,
packaging, designing of the sale pack, medical literature and documentation is to
be intimated to the licensing authority forthwith and permission to be obtained
from him within 30 days time period.
2. Information relating to Serial No. 4 and Serial No.5 are not applicable for
drugs figuring in Indian Pharmacopeia and also for the drugs figuring in United
States of Pharmacopea, European Pharmacopea, and British Pharmacopea
provided such diugs have aheady been uppioved for nuuketing in India for the
applicant under rules 122 A, 122B, 122C or 122D of the Drugs and Cosmetics
Rules, 1945.
[VFTII—Ty*S3(i)] VTOI "̂ T Tl^ra : WWI*IKUI 79
ANNEXURE-A
(See Schedule D-1I, item No.7)
INFORMATION TO BE SUBMITTED IN SCHEDULE D-H
SPECIFIC INFORMATION REQUIRED FOR THE BLOOD PRODUCTS.
A product dossier showing the:-
1. Details of source Plasma, its viral screening, storage and transport from
Collection Centres to Fractionation Centre. Regulatory status of
Collection Centres.
2. Details of Fractionation Centre, Regulatory Status, Method of
Fractionation and Control Processes.
3. Details of viral inactivation process for enveloped and non-enveloped
virus(es) and viral validation studies to assess the viral load of the product.
Testing of viral screening at any stage is to be high lighted with the details
of the kits used with their respective sensitivity and specificity.
4. Bulk filtration prior to pharmaceutical packing giving the full details of
Micro-filtration or nanofiltration followed.
5. Complete details of pharmaceutical processing and unitization.
6. Test protocol of the product showing the specifications and pharmacopeal
method followed for various testing parameters.
Specific batch test report for at least 3 batches showing the specifications
of each testing parameter.
7. Pack size and labelling.
8. Product Insert.
9. Specimen Batch Release Certificate issued by the National Regulatory
Authority of the country of origin,
80 THE GAZETTE OF INDIA : EXTRAORDINARY |PART II—SEC. 3(i)]
Specific processings like safe handling, material control, area control,
pasteurization, stability studies, storage at quarantine stage and finished
stage and packaging should be highlighted in the product dossier.
The information submitted above is true to the best of my knowledge and belief.
Place:
Date:
Signature of the manufacturer
Seal/Stamp
NB: 1. Any change in the process of manufacture, method of testing, labelling,
packaging, designing of the sale pack, medical literature and documentation is to
be intimated to the licensing aulhoiily Ibithwilh and permission to be obtained
from him within 30 days time period.
[HFTII—"0^3(0 ] , MrorwTnrra: araretrr 81
ANNEXURE-B
(See Schedule D-U, iem No.7)
INFORMATION TO BE SUBMITTED IN SCHEDULE D-II
SPECIFIC INFORMATION REQUIRED FOR THE DIAGNOSTIC KITS.
A product dossier showing llic:-
1. The details of source antigen or antibody as the case may be and
characterisation of the same. Process control of coating of antigen or
antibody on the base material like Nitrocellulose paper, strips or cards or
ELISA wells etc.
Details composition of the kit and manufacturing flow chart process of the
kit showing the specific flow diagram of individual components or source
of the individual components.
2. Test protocol of the kit showing the specifications and method of testing.
Inhouse evaluation report of sensitivity, specificity and stability studies
carried out .by the manufacturer.
3. The report of evaluation in details conducted by the National Control
Authority of country of origin.
Specimen batch test report for atleast consecutive 3 batches showing
specification of each testing parameter.
4. The detailed test report of all the components used/packed in the finished
kit.
36H7^i7<<>0j - i ;
82 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(1)1
5, Pack size and I abel I i ng,
6. Product insert,
Specific evaluation report, if done by any laboratory in India showing the
sensitivity and specificity of the kit.
Specitic processing like safe handling, material control, area control,
process control, stability studies, storage at quarantine stage and finished
stage, packaging should be highlighted in the product dossier.
The information submitted above is true to the best of my knowledge and belief.
Place:
Date:
Signature of the manufacturer
Seal/Stamp
NB: 1. Any change in the process of manufacture, method of testing, labelling,
packaging, designing of the sale pack, medical literature and documentation is to
be intimated to the licensing authprity forthwith and permission to be obtained
from him within 30 days time period.
[^FTII—TSTT 3(i)] MRff >̂I il^imi : mmUHUI 83
ANNEXURE-C
(Sec Schedule D-JI, Item No.7)
INFORMATION TO BE SUBMITTED IN SCHEDULE D-II
SPECIFIC INFORMATION REQUIRED FOR VACCINES
A product dossier showing the:-
1. History, source, date of receipt, storage, identity and characterization of
seed strain.
2. Details flow chart of manufacturing process showing all the details of
inprocess control on toxicity, potency study and stability data of the final
bulk and the final finished product including the storage temperature.
3. Complete details of chemical and pharmaceutical data for the product.
Composition and dosage form - method of manufacture with detailed flow
chart- control of starting material- control tests on intermediate and
finished products- certificate of analysis of finished products- validation of
critical manufacturing steps.
4. Test protocol of the vaccines showing the specification and method of
testing including pharmacopeal specification.
5. Specimen batch test report for at least consecutive tliree batches showing
the specification of each testing parameter.
6. The detailed test reports of all the components used/packed in the finished
vaccine.
7. Pack-size and labelling.
264<J G l / 2 0 0 1 — n
84 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
8. Product insert.
9. Specimen batch release certificates issued by the National Regulatory
Authority of the country of origin.
10. Summary of pre-clinical and clinical data including:
(a) Prescribing information.
(b) Pharmacological and toxicological data pertaining to tests on animals
Characterisation of imrriuno response and safety study in human use,
in specific Conditions.
Specific information on source of seed strain, its characterisation,
inactivation etc and processings like safe handling, material control, area
control, process control, stability studies, storage at quarantine stage and
^nished stage, packaging should be highlighted in the product dossier.
Specimen production and quality control protocols for atleast three
consecutive lots showing the specifications for each quality control
parameter including pharmacopeal requirement shall be submitted for
study.
The information submitted above is true to the best of my knowledge and belief.
Place:
Date:
Signature of the manufacturer
Seal/Stamp
NB: 1. Any change in the process of manufacture, method of testing, labelling,
packaging, designing of the sale pack, medical litcialiiie and documentation is to
be intimated to the licensing authority forthwith and permission to be obtained
from him within 30 days lime period.
[MPT I I—13^3(1) ] STOT "8RI TT3m : SU'WWK"! 85
2. All vaccines shall be new drugs unless certified otherwise by the licensing
authority approved under rule 21 of the Drugs and Cosmetics Rule, 1945, A copy
of approval of the vaccine issued by the said licensing authority is to be enclosed,
prior to issue of Registration Certificate of the said vaccines
[F. No. X-11014/8/2000-DMS &PFA]
DEEPAK GUPTA, Jt. Secy.
Footnote: The Principal rules were published in the Official Gazette vide Notification No. F. 28-10/45-H(I) dated
21st December, 1945 and last amended vide GSRNo. 242(E) dated 3-4-2001.
Printed by the Manager, Govt, of India Press. Ring R0nd, Mayapnri, New Dclhi-1 ] 0064
and Published by the Controller of Publications. Delhi-110034